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ABSTRACT

Kindlins are a novel family of cytoskeleton proteins that plays an important role
in the activation of heterodimeric integrin transmembrane receptors. These receptors play
a vital role in cell adhesion, cell migration and other cellular processes. The Kindlin
protein family consists of three homologous proteins, Kindlin 1, 2 and 3 with differential
tissue distribution and varying expression levels in human. Mutations of Kindlin 1
protein are clinically linked to Kindler Syndrome. Kindlin 2 knockdown studies have
shown embryonic lethality in mouse, but no diseases have been clinically testified.
Kindlin 3 mutations are associated with bleeding disorders, e.g. LADIII.
Talin is a cytoskeleton protein, which is a well known and widely studied
activator of integrin receptors. Talin and Kindlin bind to non-overlapping binding sites
on integrin β3 cytoplasmic tail. Their cooperation significantly enhances integrin
activation compared to integrin activation by Talin activity itself. Kindlin and Talin share
similar structural homology. A unique feature in the Kindlin FERM domain compared to
the FERM domain of Talin is that the FERM domain of Kindlin is split by a PH domain.
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The main focus of the study was to understand the role of Kindlin 2 in the
complex process of integrin activation. To gain structural insight, we have determined the
3D structure of Kindlin 2 N-terminal F0 domain by using Nuclear Magnetic Resonance
Spectroscopy. More than 90% of the backbone and side chain NMR resonances have
been assigned. Kindlin 1 and 2 F0 domains share 62% sequence homology and have a
similar ubiquitin-like beta grasp fold. However, there are distinct differences between
Kindlin 1 and 2 F0 domain structures, which may contribute to functional differences. An
in vivo assay has shown that deletion of the F0 domain from the Kindlin 2 full length
protein abolishes integrin activation. Thus, Kindlin 2 F0 domain plays a significant role
in integrin activation. Our in vitro data have shown a very weak interaction between
Kindlin 2 F0 domain and integrin β3 cytoplasmic tail /membrane/PIP. In addition, we
measured a 1µM affinity for Kindlin 2 PH domain and PIP3 interaction. Altogether these
data suggest that both the F0 and PH domains of Kindlin 2 interact with the membrane
surface and facilitate the effect of Kindlin 2 in integrin activation.
Besides Talin and Kindlin, the focal adhesion protein Migfilin, also promotes
integrin activation. It has been reported that the C terminally located LIM domains of
Migfilin, bind predominantly to Kindlin N-terminal region. We have tested the
interaction between Kindlin 2 N-terminus and Migfilin LIM domain proteins. Our data
show a weak interaction between 11-143 fragment and Migfilin LIM23 domain of
Migfilin. Though Kindlin, Talin and Migfilin are likely to be spatially close during
integrin activation, here we have eliminated the interaction between Migfilin-Talin H and
Kindlin F0-Talin H domains.
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In summary, the N-terminally located F0 domain of Kindlin 2 is crucial for
integrin activation. The interactions of the F0 and PH domains of Kindlin 2 with the
membrane suggest a role in anchoring to the membrane surface. The N-terminal 11-143
residues of Kindlin 2 are necessary for the interaction with Migfilin LIM domain.
Overall, the N-term region of Kindlin 2 plays a key role in the complex process of
integrin activation.
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CHAPTER I

INTRODUCTION

1.1 Integrins
Integrins are transmembrane cell adhesion receptors mediating cell-cell adhesion,
cell migration and other cellular processes. They are present in all metazoans but not
found in the kingdom plantae and fungi (Hynes et al., 2002). Integrins are heterodimeric
receptors formed by an α subunit and a β subunit which are non-covalently linked to each
other. Each subunit has 3 distinctive structural regions: The ectodomain, a short
transmembrane helix and the cytoplasmic peptide tail (Barczyk et al., 2000). The Integrin
ectodomain exists in two conformations: the bent conformation and the extended
conformation. In the bent conformation the subdomains of the integrin ectodomain are
more compact and the ligand binding site is faced towards the plasma membrane. This
conformation holds integrin in a low affinity state for ligand binding. In the extended
conformation the subdomains of the ectodomain of integrin are less compact and the
ligand binding site is faced towards the extra cellular matrix of the cell. This
conformation has a high affinity for ligand binding and is also termed activated integrins.
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In vertebrates the integrin receptor family consists of 24 members that are formed by 18 α
and 8 β subunits (Takada et al., 2007). These are grouped into four categories based on
ligand binding receptors: RGD receptors, Collagen receptors, Laminin receptors and
Leukocyte specific receptors (Figure 1.1).

Figure 1.1. Types of Integrin Receptors. Adopted from (Hynes et al.,
2002). In mammals, 18 alpha and 8 beta subunits are assembled in to 24
different heterodimers. Integrins are the main receptors for ECM proteins,
they can also bind to other components like receptors (ICAMs, VCAM),
molecules like fibrinogen and pathogens (e.g. viruses and bacteria).There
are different integrin subfamilies based on sequences, binding properties /
expression patterns: RGD-binding integrins in blue, the laminin-binding
integrins in purple, the leukocyte integrins in yellow, collagen binding
receptors in grey.

The 24 different types of integrin receptors have varying degrees of expression
and some have tissue specificity. For example, Integrin αIIbβ3 is present on platelet
membrane surface and recognizes fibronectins and fibrinogen. Its interaction is linked to
platelet aggregation and wound healing. α6β4 integrins are present on epithelial cell
surface and specifically binds to laminin.
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Integrin cytoplasmic tail (CT) is crucial for integrin signaling (Vinogradava, O. et
al., 2002 and others). The CT tails of the α and β subunits of integrin receptors have
conserved amino acid sequences among different members within the group
(Calderwood, 2004). Two NPxY motifs are present in almost all cytoplasmic tail
sequences of the β subunit, except in integrin β2, which has two NPxF motifs. The first
NPxY747 motif of integrin β3 is important for Talin interaction and the second NPxY759
motif interacts with Kindlin. This interaction is the hallmark for subsequent activation of
integrins.
Integrins are the largest group of cell adhesion receptor. In addition to cell
signaling, integrins also play a central role in many cellular processes. Dysfunction of
integrins has reported to cause severe embryonic malformation (Keller et al., 2001;
Martin-Bermudo et al., 1998). The function of integrin is crucial for proper homeostasis
and its regulation has been linked to many diseases such as cancer and atherosclerosis. A
large effort has been made to develop therapeutic drugs that directly target integrins
(Cox, et. al., 2010).

1.2. Integrin Activation and Signaling
During the process of integrin activation, integrins undergo a conformational
transition from a bent conformation to the extended conformation. Integrin associated
signaling is bi-directional, inside-out and outside-in signaling. A large number of proteins
are associated with the integrin in-side out signaling mechanism. As mentioned earlier,
Kindlin and Talin directly regulate integrin activation. In addition, other proteins like
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Filamin, ILK, CIB and Migfilin are also involved in tight regulation of the integrin
inside-out signaling mechanism.
At the resting state or inactive state of integrins, the interaction between the CT of
the αIIb and β3 subunits form a clasp that holds integrin at its inactive conformation.
Structural studies revealed that the PTB domain of Talin binds to the NPxY474 motif near
the membrane-proximal region of the integrin β3 CT (Vinogradova et al., 2002; GarciaAlvarez et al., 2003; Wegener et al., 2007; Yang et al., 2009). This binding eventually
disrupts the membrane-proximal clasp that holds the αIIb and β3 subunits together. This
process transforms the ectodomain of integrin from a bent to an extended conformation
which has a high affinity for ligand binding (Calderwood et al., 2002; Garcia-Alvarez et
al., 2003; Qin et al., 2004). Interestingly, most recent studies have revealed that the

Figure 1.2. Integrin activation. Adopted from Y-Q. Ma, J. Qin and E. F.
Plow, 2007.

interaction between integrin β CT and Talin is not sufficient to activate integrins at its full
activation potential. Other proteins like Kindlin act as co-activators in Talin induced
integrin activation resulting in a significant increase in integrin activation (Shi et al.,
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2007). The PTB domain in Kindlin 2 F3 subdomain interacts with the distal NxxY759
motif of the integrin β3 CT and the coordinated interaction of both Kindlin and Talin
with the integrin CT has shown to lead to an increased activation of integrins (Ma et al.,
2008; Montanez et al., 2008).
Once activated, integrins bind to extracellular matrix (ECM) ligands and transmit
signals from the extracellular matrix (ECM) to the cell interior. This pathway is the
outside-in signaling. Despite decades of studies on integrin signaling, the mechanism of
integrin activation is still not clearly understood. Not much is known about the detailed
mechanism of inside-out signaling and specifically how Kindlin and Talin cooperate to
induce potent integrin activation. We are interested in understanding the role of Kindlin
in the process of Talin induced integrin activation.

1.3. Focal adhesion
Focal adhesions are multimeric and dynamic protein complexes assembled around
activated integrins/integrin clusters which link the ECM and the cytoskeleton of the cell.
There are four levels of grouping based on factors like composition, localization and size:
focal complexes, focal adhesions, fibrillar adhesions and matrix adhesions. Each has a
distinct role in cells such as cell migration, cell-cell adhesion, cell proliferation, cell
differentiation etc. (Wozniak et al., 2004). This thesis investigates the role of key focal
adhesion proteins, integrin β3 CT, Kindlin, Migflin and Talin with particular focus on
Kindlin.
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1.4. Kindlins
Kindlins are a relatively novel group of cytoplasmic proteins. They have gained
much attention for their roles in disease development. More recently, accumulating data
for their role in integrin activation has become an area of interest (Goult et al., 2009;
Harburger et al., 2009; Larjava et al., 2008; Ma et al., 2008; Montanez et al., 2008; Moser
et al., 2008; Ussar et al., 2006). However, not much is known about the structural details
of Kindlins or its role in integrin activation.

1.4.1. Kindlin protein family
The Kindlin protein family in human consists of three homologous proteins,
Kindlin 1, 2 and 3. Kindlin 1 was the first to be identified by Siegel et al. This group
further identified two additional Kindlin 1 like proteins, MIG-2 and MGC10966, which
they renamed as Kindlin 2 and Kindlin 3 respectively (Siegel et al., 2003). The first
Kindlin ortholog to be identified was UNC-112 in C. elegans. All Kindlin proteins and
UNC-112 share common features in their domain structure and amino acid sequences.

Figure 1.3. Kindlin-1 protein structural domains.(Goult et al., 2009).
Kindlin 1 and 3 proteins have similar structural domains. The F2 subdomain
is split by a PH domain, the F0 domain is located at the very N-terminus and
the F3 subdomain at the C-terminus.
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All Kindlin proteins have a FERM domain and a N-terminally located F0 domain. A
unique feature of Kindlin FERM domain compared to other FERM domains of all other
proteins is that the F2 subdomain of the FERM is split by the PH domain (Fig 1.3). To
date the structure of F0 subdomain of Kindlin 1 has been elucidated by Goult et al. (Goult
et al., 2009).
PH domains (Plekstrin Homolgy domain) are present in many proteins. They are
known to bind to phosphoinositides with specificities to the inositol ring, helping in
localizing proteins to the membrane surface and involving in regulatory mechanisms. PH
domains that bind to G proteins and protein kinase C are part of signal transduction
pathways (Shaw, G., 1996). The role of the PH domain of Kindlin is not yet known.
FERM domains are evolutionary conserved structural domains which serve in
various cellular signaling mechanisms. They consist of 3 subdomains, F1, F2 and F3.
FERM domains are found in many proteins and bind with specificities to
phosphoinositides. Both Talin and Kindlin have FERM domains. The F3 subdomain of
Kindlin and Talin show similar homologies and are known to bind to non-overlapping
sites of integrin β3 cytoplasmic tails. Talin F3 subdomain binds to phosphoinositides and
its interaction activates Talin for subsequent interaction with integrin CT (Goksoy et al.,
2009). The interaction between Kindlin F3 subdomain and phophoinositides remains for
potential investigation.
Kindlin proteins are encoded from 3 different chromosomes. Kindlin 1 from
chromosome 20, Kindlin 2 from chromosome 14 and Kindlin 3 from chromosome 11
(Weinstein et el., 2003).
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Kindlin 1 or FERMT1 is 677 residues in length and has a molecular mass of 77.3 KDa.
Siegel et al. group have first demonstrated that Kindlin co localizes with vinculin in focal
contacts. Kindlin 1 is a phosphoprotein where the serine residues at position 170 and 179
are phosphorylated (Dephoure N., et al., 2008). There are four isoforms described in
Kindlin

1

protein

but

their

individual

functions

are

not

known

(http://www.uniprot.org/uniprot/Q9BQL6).
Kindlin 2 is a 68KDa protein and is 680 amino acids in length. It displays 60% sequence
identity to Kindllin 1 and 49% sequence identity to Kindlin 3. Human Kindlin 2 two exist
in

two

isoforms

produced

by

alternative

splicing

(http://www.uniprot.org/uniprot/Q96AC1). Isoform 1 is considered as the canonical
sequence. Kindlin 2 isoform has certain differences at the C terminus: residues 627-680
are missing, residues 625-626 are TV→NS and residue 534 is an insertion of
Q→QPGYIRDL. Phosphorylation of serine residues at position 159, 181 and 666 of the
sequence have been identified in Kindlin 2 (Ussar et al., 2006). A unique feature of
Kindlin 2 sequence among other Kindlin proteins is the nuclear localization signal (NLS),
which spans between 152-172 amino acid region.
Kindlin 3 is 677 residues in length and is widely known as FERMT3. Kindlin 3 is
expressed in the hematopoitic tissues and plays a fundamental role in cell adhesion,
integrin activation, wound healing etc. Kindlin 3 is also found as two isoforms in human,
(http://www.uniprot.org/uniprot/Q86UX7) residues 360-363 in isoform 2 are missing
from isoform 1 sequence. Post-translational phosphorylations are identified at positions 8,
11 and 504 of the sequence.
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1.4.2. Diseases associated with Kindlins.
Kindler syndrome is a rare but severe skin condition, which is caused by
autosomal recessive genes of KIND1 mutation/s. It is the first skin disorder, which has
been identified to occur due to a non-systematic connection of the cell between the extra
cellular matrix and actin cytoskeleton (Siegel et al., 2003). Major symptoms appear to be
skin blistering due to skin fragility, sensitivity to the exposure of the sun, unusual
melanin distribution and wrinkling of the skin. Altogether the individual shows a
prematurely aged appearance at early childhood (Theresa Kindler in 1954).
To date there are no diseases related to Kindlin 2 mutations. Kindlin 2 knock
down mice are embryonicaly lethal heightening the significance of Kindlin 2 during
embryogenesis. In fact Kindlin 2, among other Kindlin proteins plays a central role in
early cardiogenesis (Mackinnon et al., 2002; Williams and Waterston, 1994; Xu et al.,
2006). Its crucial role might not be completed with impaired functions of the protein.
LAD-III is a leukocyte adhesion deficiency syndrome and is linked to Kindlin 3
mutations. Patients with LAD-III have an extended bleeding time and show a lack of
ability of leukocytes to bind to the ECM.
Despite a lot of studies have focused on diseases associated with Kindlins, not
much is known about the disease pathologies. Even less is known about the particular
functions and structure of Kindlin proteins.

1.4.3. Tissue Distribution and Biological Roles of Kindlins.
Kindlins are widely expressed in the human body. Ussar et al. have shown the
distribution of Kindlin proteins in adult and embryonic mouse. Kindlin 3 expression is
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found in all hematopoetic tissues: spleen, thymus, lymph node, and lungs (Fig 1.4.).
Mouse Kindlin 2 RNA expression was observed in all tissue types with a high level of
expression in heart, lung, skeletal muscle, bladder, stomach and kidney. Kindlin 1
showed a higher expression of RNA levels in the colon, and bladder compared to a
weaker expression in the skin, intestine and kidney. The expression of Kindlin 1 protein
in the dermis of the skin is much weaker than in the expression of the epidermis, whereas
the reverse is true for Kindlin 2 expression. Interestingly, malfunction of Kindlin 1 in the
epidermis cannot be compensated by epidermal Kindlin 2 or with dermal Kindlin 1. This
implies different functions of Kindlin 1 and 2 in the epidermis, and is the underlying
cause for the Kindler Syndrome (Ussar et al., 2003). Another study has shown that
Kindlin proteins have different sub cellular localization (Bailkowska et al., 2010).
In addition to differential tissue expression, cancer cells also report an increased
expression of Kindlin 2 protein. Kindlin 2 was up regulated in the nucleus of cancer cells
suggesting that Kindlin 2 plays a major role in tumor growth (An et al., 2010b; Wu,
2005).
A recent study by Has, C. et al. revealed a role in Kindlin2 in adult skin tissue.
Kindlin 2 is strongly up-regulated during wound healing of the human skin. It has shown
to initiate integrin clustering and activation in fibroblasts cells, subsequently regulating
the formation and maturation of focal adhesions and reorganization of the actin
cytoskeleton (He et al., 2010). In myocytes, Kindlin 2 localizes to Z-discs of
cardiomyocytes (Ussar et al., 2006).
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Figure 1.4. Tissue distribution of Kindlin proteins. Adopted from (Ussar et
al., 2006).

1.4.4. Binding partners of Kindlin.
There are three groups of proteins been identified in literature that interacts with
Kindlin (An et al., 2010a). They are integrin β1, β2, β3 cytoplasmic tails, ILK and
Migfilin.
Integrin β1, β2 and β3
Using keratinocytes from normal and Kindler Syndrome patients, Siegel et al.
have first demonstrated that there is a direct correlation between Kindlin 1 and integrin
β1 activation (Siegel et al., 2003). Kindlin 1 protein has shown to bind directly to β1 and
β3 integrins (Harburger et al., 2009)(Ussar et al., 2008). The FERM domain of Kindlin 1
and 2 is sufficient for the interaction with integrin β CT (Harburger et al., 2009; Shi and
Wu, 2008). Within the FERM domain, the F3 subdomain is important for the interaction
11

with integrin. Mutations of residue K610, W612 and L651 to Alanine in Kindlin 1 completely
suppress the interaction to integrin β1 tail. In Kindlin 2, the mutation of W615 showed a
dramatic effect on β3 interaction and subsequent integrin activation (Ma et al., 2008).
Recent studies have shown that tyr795 phophorylation has a low affinity for Kindlin 2
binding. These data suggest a regulatory mechanism of Kindlin 2 in integrin activation
(Bledzka, K. et al., 2010). In addition, Kindlin 3 has shown to bind to β2 integrin on
neutrophils and promotes integrin activation (Moser et al., 2009).
Kindlin and Talin bind to different regions of the integrin CT and promote
integrin activation. But how exactly these two binding events promote integrin activation
remains elusive.
Migfilin.
Migfilin protein was first identified as a Kindlin binding protein (Tu et al., 2003).
Migfilin, also known as Cal (Akazawa et al., 2004) or FBLP-1A (Takafuta et al., 2003),
is a 367 amino acid protein. It has central proline rich region, an unstructured N-terminal
region and three C-terminal LIM domains. There are three homologous Migfilin proteins
in human (Figure 1.5). The Migfilin(s) homolog lacks the proline rich region in its
structure, whereas the FBLP-1 lacks the LIM 3 domain. Migfilin has multiple binding
partners; the LIM domains of Migfilin mediate the interaction between Migfilin and
Kindlin 2. This interaction is required for the recruitment of Migfilin to the focal
adhesions. The N-terminal region of Migfilin binds to Filamin and inhibits the negative
regulatory effect of Filamin in integrin activation (Kiema et al., 2006; Ithychanda et al.,
2009a; Wu, 2005). Src is a protein kinase, which also interacts with Migfilin, which has
shown to protect the process of anoikis (Zhao et al., 2009).
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Migfilin has multiple roles and different co-localizations in the cell. In the nucleus
it serves as a transcription co-factor. And in the cell cytoplasm, it interacts with cadherin
β catenin complex for cell-cell adhesion. And recruitment to focal adhesion is
accomplished by interacting with Kindlin.

Figure 1.5. Migfilin interacting domains. (Wu, 2005). There are 3
isoforms of Migfilin in human. Migfilin, Migfilin(s) which lacks the proline
rich region and FBLP-1 which lacks LIM 3 domain. Four binding partners
of Migfilin have been identified so far. Mig-2 or Kindlin 2 interacts to
LIM23 domain.
ILK.
Integrin linked Kinase shortened as ILK was first identified as an integrin β1
binding protein in 1996 (Hannigan et al., 1996). ILK is a 59kDa, comprises of a
pseudokinase domain, a PH domain and (Fukuda et al., 2009) four ankyrin like repeats.
Kindlin 2 is required for the localization of ILK to focal adhesions (Montanez et al.,
2006). Interestingly, both ILK and Kindlin 2 were overexpressed at the growing front of
malignant mesothelioma tumor and weakly expressed at the middle of the tumor. This
shows that both ILK and Kindlin 2 are important for cell migration (An et al., 2010b).
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The interaction between ILK and Kindlin has not been investigated at the molecular
level.

1.5. Aim of the project
Despite the detailed information on the clinical significance and biological role of
Kindlin proteins, much is not known about the mechanism of cooperate regulation of
Talin and Kindlin in integrin activation. Moreover, even less is known about the
structural aspects of Kindlin proteins and their functions. This thesis focuses on
investigating the molecular mechanism of Kindlin, predominantly Kindlin 2, and its
binding partners in regulating Talin induced integrin activation.
Based on facts from literature, we have proposed a model for integrin activation,
which is shown in a schematic diagram in figure 1.6. The model suggests that Filamin is
bound to integrin at the resting or inactive states of integrins. Migfilin is able to bind to
Filamin and displace Filamin from the integrin β CT. This interaction makes the integrin
β CT available for potent activation by Talin and Kindlin, a key process of all cell
adhesive processes. Data from our laboratory have shown that Migfilin displaces Filamin
from integrin and promote integrin activation (Ithychanda et al., 2009b; Ithychanda et al.,
2009c). However, some of the key aspects of the model are yet to be proved.
In vivo studies by Tu and co-workers have shown that Migfilin is recruited to
focal adhesion sites via Kindlin 2. More specifically, the LIM domains of Migfilin have
shown to be responsible for this interaction with Kindlin 2 (Tu et al., 2003). The
interaction between Kindlin C-ter and integrin has been established through several
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studies (Ma et al., 2008; Malinin et al., 2010). The binding interface between Kindlin and
Migfilin is assumed to be between the LIM domains of Migfilin and Kindlin N-ter
region. But how exactly this binding interaction occurs is not clear. In addition how
significant this binding interaction is for integrin activation and subsequent cellular
processes needs to be evaluated and will be addressed in this thesis.

Figure 1.6. A model for the Migfilin/filamin interaction in regulating
integrin activation and cytoskeleton reassembly. Migfilin is recruited by
Kindlin-2 (Mig-2) to integrin adhesion sites (Tu et al., 2003). The recruited
Migfilin promotes the dissociation of inhibitory filamin from integrins and
facilitates the talin/integrin interaction as well as the anchoring of kindlins
to integrin beta CTs and strengthens the talin effect in integrin activation.
Since filamin is a major actin crosslinking protein critical for maintaining
the actin network, the Migfilin-induced disconnection between integrin and
filamin may also cause temporal rearrangement of the integrin-actin linkage
to facilitate the cytoskeleton remodeling.
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Another interesting aspect of the model is how Kindlin interacts with the integrin
CT and other proteins to facilitate directly or indirectly in Talin induced integrin
activation. Talin is a known activator of integrin activation and the mechanism of integrin
activation and the auto inhibitory mechanisms are well established (Goksoy et al., 2008)
(Shattil et al., 2010) (Vinogradova et al., 2002; Vinogradova et al., 2004). However, the
contributory mechanism of Kindlin in Talin induced integrin activation is unclear. It has
been shown through various functional assays from our collaborators’, that the interaction
between Kindlin 2 PTB domain and integrin β3 CT has a pronounced effect on integrin
activation. More specifically phosphorylation of Y759 of integrin CT has a negative effect
on Kindlin 2 binding (Shi et al., 2007; Ma et al., 2008; Bledzka et al., 2010). Up to date
there is no structural information on the interaction between Kindlin 2 C-terminal F3
domain and integrin. We aim to understand the interaction between Kindlin 2 C-ter and
integrin through structure based analysis and understand its role in the mechanism of
integrin activation.
Lack of descriptive information about the structural details of Kindlin 2 in
literature makes it difficult to evaluate our hypothesis to understand its function. To have
a better understanding of the protein in a structural point of view, we have obtained a
model structure of the full length Kindlin 2 protein.
To evaluate our hypothesis’s we undertook a vigorous structure based investigation
approach using NMR as our major tool. A structural analysis allowed us to understand
the molecular mechanism of interaction and pin down the exact binding interfaces.
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Our aims are as follow:
1. To solve the structure of Kindlin 2 N-ter.
2. To understand the functional significance of Kindlin 2 N-ter.
3. To resolve the structural determinants of Kindlin 2, Talin and Migfilin.
4. To understand and evaluate the interactions of Kindlin 2 C-ter.
Overall, both in vivo and in vitro experiments should help us to elucidate the
mechanism of cooperate regulation of integrin. This work broadens our understanding of
how Kindlin 2, Talin and Migfilin interactions mediate integrin activation. To date, there
is a lack of information about the structural details of Kindlin and its interactions in
particular. These aims will give us a molecular level understanding about the subdomain
structure and function of Kindlin 2 and will help us to understand the pathogenesis of
related human diseases.
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CHAPTER II

TECHNIQUES IN STRUCTURAL BIOLOGY

2.1. Nuclear Magnetic Resonance Spectroscopy
2.1.1. Overview
NMR is a branch of spectroscopy where the inherent property of magnetization
splitting of nuclei is observed by the interaction of radio frequency wave. This
phenomenon was observed in 1946. Since then a large number of discoveries in the field
of NMR have led to applications like macromolecular structure determination, Magnetic
Resonance Imaging, interaction studies such as molecular dynamics and kinetics. NMR is
the only technique available which allows performing experiments in all three states of
matter, solid, gas and liquid. Liquid NMR is the most common of all for small molecules
like organic compounds, pharmaceuticals and macromolecules such as protein, DNA etc.
Solid state NMR is becoming popular, to overcome certain drawbacks in liquid NMR.
NMR on gaseous samples is the least common in the field.

18

NMR is one of the two techniques available to determine three dimensional structures at
atomic resolution. Macromolecular X-ray crystallography is the other.

Despite the

occurrence of a huge percentage of protein crystal structures in the protein databank,
NMR has been the method of choice in understanding the dynamic function of a binding
interaction (Wuthrich, 1991). The significance of the NMR technique was appreciated by
winning the Nobel prizes in 2002 - Kurt Wurthrich, 2001- Richard. R. Ernst, 1952 – Felix
Bloch for their contributions. The discovery of Fourier transformation and the
development of multi dimensional NMR spectroscopy in the late 1960 were the most
important turning points in the field of NMR. Advancement from fully-manual to semiautomated with the improvement/development of various computer software packages
and the discovery of recombinant protein technology improved the area of 3D biological
structure determination. Nowadays, NMR is playing an important role in 3D structure
determination, structural genomics and protein-protein interaction studies.
The goal of this thesis is to understand the molecular role of Kindlin 2 in integrin
activation. The structure of Kindlin 2 protein helps us to elucidate the binding
interactions at an atomic level. Here we have used NMR as the method of choice for
structure determination of Kindlin 2 F0 subdomain. In addition, we used NMR as our
primary tool to understand protein-protein interactions.

2.1.2. Protein structure determination
Protein structure determination is a multiple step process (Wuthrich, 1989a;
Wuthrich, 1989b). In brief, the first step in the process of protein structure determination
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is sample preparation, which is followed by data collection, data processing, assignment
and structure calculation. A very short outline of each step is described below.
Sample preparation
A typical NMR sample for structure determination must have an average
concentration of 1mM protein. With the development of Shigemi NMR tubes the volume
requirement has significantly reduced from 0.4ml to 0.2ml. Isotope labeling is another
requirement for protein NMR, which reduces spectrum complexities and eases the
process of structure determination.
Proteins comprise of naturally occurring isotopes of

12

C, 1H,

14

magnetically active atom that plays a key role in NMR. Although

N etc. 1H is a
12

C nuclei is

magnetically inactive and 14N is less sensitive for detection, their corresponding isotopes,
13

C and

15

N, are magnetically active and sensitive for detection (spin half) and can be

easily incorporated into proteins using isotope labeling methods (Sambrook et al., 1989).
Isotopic labeling is an essential step in a wide range of applications in NMR (Montelione
et al., 2000; Shuker et al., 1996). Currently, the most widely used method for labeling
proteins is recombinant protein expression. A 1H,

13

C and

15

N triple labeled protein

sample increases NMR spectral resolution and simplifies subsequent structure
determination steps.
NMR spectra - data collection
For small proteins with less than 50 amino acids (<10KDa), homonuclear 2D
experiments such as COSY, TOCSY and NOESY are sufficient for structure
determination (Wuthrich et al., 1982). However, for larger proteins (>100 amino acids)
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homonuclear spectra become crowded and heteronuclear multidimensional experiments
are necessary for better signal resolution and less spectral complexities.
The most widely used heteronuclear 2D NMR technique is HSQC (heteronuclear
single quantum coherence). The magnetization is transferred from 1H backbone proton to
the attached

15

N of backbone NH2 group via scalar couplings. Thus each amino acid in

the protein with N-H group gives a signal in an HSQC spectrum.
To further simplify and improve resolution of protein spectra for the
determination of structure, 3D NMR experiments are crucial. A number of triple
resonance NMR experiments were developed for

15

N,

13

C and 1H/2H isotope labeled

proteins.
Assignment
The process of cross-connecting resonance signals of NMR spectra to atomic
nuclei of proteins is termed assignment. The assignment process has two steps. First, the
backbone assignment of the protein and second the side chain assignment of each amino
acid of the protein. There are different sets of multidimensional through-bond
experiments, which transfers magnetization through the peptide bonds and are used for
the resonance assignment of protein.
For small proteins the most simple and straightforward method for protein
backbone assignment is to analyze CBCANH and CBCACONH spectra. An alternative
method for large proteins with >100 amino acid residues is to find backbone linkages
through HNCO, HNCACO, HNCA and HNCACO NMR spectra (Muhandiram and Kay).
Nowadays, computer programs are used for the semi-automatic backbone assignment of
proteins. MARS, PASA, GANA are well-known among them. The side chain resonances
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are commonly assigned through HCCH-TOCSY. This experiment couples aliphatic side
chain protons and

13

C resonances through J-coupling constants. Once the resonance

assignment is complete the next step is restraint generation.
Restraints
There are several types of restraints that are used for structure determination: (1)
Distance restraints are the distance between two atoms; these are obtained from NOESY
spectra (Jeener et al., 1979; Williamson et al., 1985; Williamson et al., 1985). (2)
Dihedral angle constraints from J coupling constants and chemical shifts; obtained
automatically through TALOS program. (3) Residual dipolar couplings. (4) H-bonds and
disulfide bond restrains.
In NOESY experiments, the magnetization is transferred through-space between
nuclei close in proximity via nuclear Ovenhausen effect. The intensity of a peak in a
NOESY spectrum is related to the distance between the two proton nuclei (Wiliamson et
al., 1985). Ideally, the intensity of a NOESY cross-peak is directly proportional to 1/r-6
of the distance between the two atoms. But experimentally this is not always true.
Various factors affect the NOE signal intensity such as indirect magnetization transfers
due to spin diffusion.
TALOS is a program (Cornilescu et al., 1999) that searches a database of high
resolution protein structures. It relates experimentally measured backbone chemical shifts
to chemical shifts in already known secondary structures, and correlates that to backbone
torsion angles.
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Structure calculation
The next step is structure calculation. Various software packages are used for
structure calculation: XPLOR-NIH, CYANA etc. All restraints that were determined
experimentally are used as an input for calculating an ensemble of 3D structures.
The quality of NMR structures
There are several parameters to access the quality of NMR structures. One
measure is the convergence. A high convergence of the calculated ensemble of
superimposed structures reflects by the low standard deviation of the coordinates of the
structures. However, a good convergence does not necessarily represent the accuracy of a
structure. The Ramachandran plot is another parameter which evaluates validity of the
backbone torsion angles (Ramachandran et al., 1963). The backbone of a protein should
have a RMSD (measures the position of each atom coordinate on average throughout all
the structures) of 0.4º and side chain atoms a RMSD of 1.0º for a structure with high
precision. A high resolution NMR structure has on average 15-20 NOE distance restraints
per residue and 3.5 long range distance restraints per residue in the structured regions.

2.1.3. Methods and materials
We acquired all NMR experiments at 298K under 600, 800 and 900 MHz
BRUKER AVANCE spectrometers equipped with a cryoprobe. We used NMR-PIPE
(Delaglio et al., 1995), PIPP (Garrett et al., 1991), NMRDraw and NMR View (Johnson
and Blevins, 1994) to process out NMR data.
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NMR sample preparation and data collection for structure calculation
I prepared a 1mM of 15N and

13

C labeled Kindlin 2 1-105 sample for NMR data

collection and dialyzed the protein against a buffer solution containing 50mM Sodium
phosphate, 100mM sodium Chloride, 1mM DTT, 0.05% of sodium azide at pH 6.8, with
a final of 10% (v/v) D2O. HNCA (Kuboniwa et al., 1994), HNCO, HNCACB
(Muhandiram and Kay), HNCACO, HSQC and CBCACONH spectra were acquired on a
cryoprobe equipped 600 MHz spectrometer.
I prepared a 100% D2O sample for 2D-TOCSY experiment, and an isotopically
unlabeled 1mM Kindlin 2 1-105 sample for the collection of NOESY spectra.
Protein backbone assignment
We used PASA protocol for the initial semi-automatic sequential backbone
assignment (Xu et al., 2006). We analyzed the ambiguous connections manually using
HNCO - HNCACO and HNCA - HNCACB for the sequential assignment of backbone
amides.
Protein side chain assignments
We used HCC(CO)NH and CC(CO)NH triple resonance spectra for assigning
hydrogen nuclei and carbon nuclei respectively. In addition, we used HCCH-TOCSY
experiment and NOSEY experiments to assist in the protein side chain assignment.
Interaction studies
For 2D

15

N-1H-HSQC (Kay et al., 1992) experiments, 0.05-0.2mM protein

samples were dialyzed against 50mM Sodium phosphate buffer containing 100mM
Sodium Chloride at pH 6.8 buffer. I removed DTT from the buffers during interaction
studies with Migfilin LIM domains but was present for all other experiments. We used
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the pulse sequences dk-hsqc and fhsqc3gpph for almost all HSQC experiments. We
collected spectra on a BRUKER AVANCE ICE spectrometer equipped with a cryoprobe.

2.2. Recombinant protein expression and purification
The requirement of a high concentration of protein is one requirement for NMR.
A typical NMR sample for structural studies needs around sub molar concentration of
protein. Such high amount of protein is difficult to purify from native cells i.e. it’s time
consuming and non economical. Recombinant Protein Expression technologies are
commonly used to obtain a high concentration of pure protein.
Fusion proteins are used for the ease of purification. Histidine tag, Glutathione
transferase Tag and Maltose binding protein Tag are commonly used fusion proteins
which ease the isolation of target protein from crude lysate.

2.2.1. Protein expression optimization
Theoretically, recombinant protein expression techniques have a potential to
express high levels of proteins. However, this is not observed in vivo. There are a
limitless number of factors that suppress, limit, and prevent the expression of
recombinant proteins in E. coli bacteria. In addition, the expressed protein can encounter
endless factors which prevent it from being able to isolate. The stability of the protein is
one important factor which reduces the yield of the protein. The instability could be due
to many reasons such as prone for proteolytic cleavages, inherent instability of the protein
etc. Precipitation of the protein is another factor which reduces the final yield of the
protein. Protein aggregation is a common incident in recombinant protein expression
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systems. Aggregation can be explained as a process of oligomerization of protein. This
could be lower oligomer formation such as dimers, trimer, tetramer or higher oligomers.
Lower oligomers are manageable for functional analysis.

Oligomerization can be

nonspecific by forming aggregates. Most often unfolded proteins and very hydrophobic
proteins have a tendency to form massive aggregates. In fact, there are many other
reasons which abolish the expression of a protein which will not be discussed in detail
here.

2.2.2. Materials and methods
Kindlin 2 constructs.
We used the cDNA of full length human Kindlin 2 as a template for subcloning. I
chose the boundaries for each protein according to secondary structure prediction of the
full length Kindlin 2 obtained from the PSIPRED web server. In later subclonings, I used
the 3D model structure of full length Kindlin 2 to assist in choosing the boundaries of the
protein. For Kindlin 2 N terminal sequences, I used EcoRI and XhoI or XbaI restriction
enzyme sites to clone the insert into the cloning vector. For C terminal sequences, I used
either BamHI and NotI, or BamHI and XbaI restriction enzyme sites for cloning
purposes. The cDNA of the C-terminal FERM regions have multiple restriction enzyme
sites within their sequences. I cloned the cDNA of each insert in to cloning vectors shown
in Table 2.1: PGEX-4T-1 (Pharmacia) or pGEX-4T-1 derived parallel GST 1 (pGST-1)
for GST fusion proteins, pHis-1 or pET30a or pET15b for His-tagged fusion proteins and
pMAL-c2x or pMBP-1 for MBP fusion proteins. I cloned some sequences into pMALc2x-His tag engineered cloning vector which was kindly provided from Dr. Jun Yang. I
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transformed the cloned protein expression vectors into DH5α bacterial host strains and
plated on appropriate antibiotic resistant plates. The bacterial colonies were subjected to
colony PCR (Sambrook) to screen for positive colonies bearing our cloned insert. We
used a Miniprep or Midiprep preparation (Promega) to isolate DNA plasmids from
bacterial cells of our cloned protein expression vectors. Finally, I used the support of the
CCF sequencing core to verify the accuracy of the cloned sequences. I transformed
KINDLIN-2

FUSION

BACTERIAL

BOUNDARIES

TAG

HOST STRAIN

1-134

HIS

Rosetta 2

GST

Rosetta 2

1-154

HIS

Rosetta 2

1-158

HIS

Rosetta 2

1-218

GST

Rosetta 2

11-177

GST

Rosetta 2

11-143

HIS

Rosetta 2

GST

Rosetta 2

GST

BL21(DE3) gold

MBP

Rosetta 2

MBP

BL21 (DE3) RIP

MBP-HIS

Rosetta 2

GST

BL21 (DE3) pLys

HIS

BL21 (DE3) pLys

GST

Rosetta 2

GST

Rosetta 2

GST

Rosetta 2

95-276

GST

Rosetta 2

95-168

GST

Rosetta 2

95-268

GST

Rosetta 2

95-154

GST

Rosetta 2

155-268

GST

Rosetta 2

1-105

Table 2.1. Kindlin-2 N’ term recombinant proteins.

27

KINDLIN-2

FUSION

BACTERIAL

BOUNDARIES TAG

HOST STRAIN

565-658

BL21 (DE3)

GST

MBP-HIS BL21 (DE3)
BL21 (DE3)
Rosetta (DE3)
Rosetta 2 (DE3)
567-662
567-665

HIS

Rosetta 2

GST

Rosetta 2

HIS

Rosetta 2

GST

BL21 (DE3) pLys
Rosetta 2

567-680

GST

BL21 (DE3) pLys
Rosetta 2

485-665

GST

BL21 (DE3) pLys
Rosetta 2

395-567

GST

Rosetta 2

459-567

GST

Rosetta 2

477-567

GST

Rosetta 2

Table 2.2. Mig-2 C’ term recombinant proteins.
sequence verified protein expression vectors into one or more protein expression E.coli
bacterial strains, BL21 (DE3), BL21 (DE3) pLys, BL21 (DE3) pLys Gold, BL21 (DE3)
RIP (Stratagene) and Rosetta 2.
Migflin constructs.
cDNA of human Migfilin(s) was kindly provided from our collaborators. I used
PCR to amplify the cDNA of the C terminal LIM domains, LIM123 (residues 172-367
and 172-373), LIM23 (residues 241-367 and 241-373), LIM2 (residues 241-304) and
LIM3 (residues 298-367) of human Migfilin. We used a high fidelity DNA polymerase,
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Pfu Ultra DNA polymerase (Invitrogen), for PCR reactions. I used parallel GST-1 and
parallel His-1 vectors for most of the cloning work. All parallel vectors were kindly
provided by Dr. Saurav Misra. I transformed sequence verified protein expression vectors
into Rosetta 2 (DE3) for subsequent protein expression.
Talin constructs.
Full length human Talin 1 encoding cDNA sequence was provided from Dr. Ma
Yang-Qing. I cloned Talin head domain and its subdomains into parallel His-1 vectors. I
ordered all primers from Integrated DNA technologies, and used PCR with primers
consisting EcoRI and XhoI restriction sites to amplify cDNA of Talin F0 domain residues
1-86, Talin F0F1 residues 1-206, Talin F1 residues 86-206, Talin F2F3 residues 206-429
and Talin H (F0F1F2F3 residues 1-429). I transformed the sequence verified constructs
into BL21 (DE3) for protein expression.
Optimization.
All constructs were optimized for their expression and protein solubility at
varying temperatures. I used induction temperatures ranging from 15ºC, 20ºC, 25ºC and
37ºC for a temperature dependant optimization, IPTG concentrations between 0.2mM
and 1mM for optimization for protein expression, and time of induction from 4hrs, 16hrs,
18hrs and 24hrs. I employed this approach for almost all constructs individually.
We implemented an intense optimization approach for Kindlin 2 11-143
construct. For this construct besides the aforementioned optimization strategy I
performed the following strategies to increase the final yield of the protein: protein refolding using decreasing percentage of urea and Foldt Screen (Hampton Research), autoinduction medium for protein expression, chaperone assisted folding (Takara) by co-
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expression of chaperones, applying a cold shock and heat shock for bacterial cells, codon
optimization for bacterial expression, varying of vector i.e. fusion tags (GST, HIS, MBP,
MBP-HIS, NUS-HIS), surface cysteine mutation, and use of a variety of detergents.
Protein expression and purification.
After optimization, we expressed the fusion proteins in LB (Lennox L Broth)
culture media or TB (Terrific Broth) culture media (RPI co-operation) and harvested at
3500rpm for 15min (Sorvall). We suspended the cell pellets in the lysis buffer which was
incorporated with 10mg of lysozyme per 50ml lysis buffer, EDTA free protease inhibitor
cocktail (Biocompare), deoxyribonuclease and Magnesium ions. We froze the mixture in
liquid nitrogen and incubated the frozen cell pellets at 4ºC with slow rotation overnight
for cell lysis. The cell lysis procedure for proteins that tend to be unstable (Kindlin 2 168268) was different. Those cells were immediately ruptured after harvesting by mechanical
methods using a French-press or short pulses of sonication. I used phosphate buffered
saline (PBS) as the lysis buffer for GST fusion proteins, a 20mM Tris buffer with 0.2mM
NaCl, 1mM EDTA, 10µM beta mercapthoethanol buffer solution as the lysis buffer for
MBP tagged protein and 300 mM phosphate buffer with 500 mM NaCl, pH 8.0
containing 10mM imidazole for His fusion proteins.
We purified the fusion protein using affinity chromatography with Nickel-NTA
resin (Qiagen), Glutathione sepharose 4b resin (GE healthcare), and amylose resin (NEB)
for each HIS, GST and MBP fusion protein purifications respectively. We cleaved the
fusion tag with a suitable protease which is TEV protease for proteins derived from
parallel cloning vectors, Thrombin protease (Sigma) for pGEX derived cloning vectors
and pET15b and Faxtor Xa protease (Novagen) for pET30a cloning vectors in
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appropriate buffers and cleavage conditions. We further purified the protein using size
exclusion chromatography, either Superdex 75 or Superdex 200 matrix (Amersham
Bioscience) depending on the size of the protein.
Isotope labeling
Isotopically labeled proteins are required for 3D NMR experiments for structure
determination. We used

15

NH4Cl as the 15N source and

13

C glucose as the

13

C source in

culture medium to obtain 15N and / or 13C enriched proteins.
During isotopic labeling of Zinc finger proteins, I added 1ml of 0.1M ZnCl2 per 1L to the
media just before induction of protein. We routinely performed overnight induction either
at room temperature or at 20ºC. For Migfilin LIM domains, the best optimization
condition in LB is induction overnight at 15ºC, and for isotope labeled LIM domains the
best induction temperature was 25ºC.
Mutagenesis
Kindlin 2 11-143 protein has two Cysteines. I introduced a point mutation at
C12S of Kindlin2 11-143 construct using the Quick Change Site Directed Mutagenesis
Kit (Stratagene).
I prepared a sequence deletion mutation for the integrin activation assay
performed by Dr. Ma. I deleted residues ranging from 11-143 from the full length Kindlin
2 sequence using Quick Change Site Directed Mutagenesis Kit (Stratagene).
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2.3. Macromolecular X-ray crystallography
Besides NMR, macromolecular X-ray crystallography is the widely used
technique for 3D protein structure determination. More than 80% of the protein structures
deposited in the protein data bank (PDB) are derived from X-ray crystallography. The
basic principle in X-ray crystallography relies on the diffraction of the X-ray wave by the
electron cloud of the protein. Structure determination by X-ray crystallography involves
multiple steps. The major requirement for X-ray structure determination is the
requirement of a ‘solid’ protein crystal. The crystal should be >10A° in length in all 3
dimensions, with uniform composition and lack of physical imperfections. The crystal is
placed in an X-ray beam and its diffraction patterns or reflections at continual angles
throughout the crystals z axis are recorded. All recorded reflections are processed via
mathematical formulations computationally and subsequent refinement produces a 3
dimensional protein structure.
Structure determination by X-ray Crystallography takes less time and is automatic
compared to NMR that takes a longer time with more manual involvement. NMR protein
structure determination is limited to 30-40 kDa protein whereas in X-ray Crystallography
there is no size limitation. However, X-ray crystallographic approaches always require a
crystal or multi crystal complex of the protein, which limits its usage as some proteins are
difficult to crystallize or not able to crystallize at all. Most importantly, X-ray
crystallography will not show the dynamic effects of an interaction process, rather it
gives a snapshot of an end result of an interaction. Therefore, besides structure
determination, NMR plays a crucial role in the understanding of the dynamic function of
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a binding interaction process. (Wuthrich, 1991). Besides NMR, we used X-ray
crystallography as an alternative step for protein structure determination.

2.3.1. Materials and methods
Kindlin 2 11-143 and 1-105
We expressed Kindlin 2 11-143 and 1-105 protein expression constructs as a GST
fusion proteins in E. coli BL21 (DE3) pLys cell line. A cold shock was applied to cell
cultures by incubating the cultures in an ice-water bath for 30 min, followed by induction
with 0.5mM IPTG at room temperature 298K for 16hrs. The purified protein was
concentrated to 1mM (15mg/ml) and dialyzed overnight into crystallization buffer
containing 20mM Tris-HCl, 50mM NaCl, pH 7.0, and 1mM DTT. We transformed
Kindlin 2 11-143 construct into B834, a Methionine auxotroph bacterial strain of E. coli,
to obtain Selenomethionine labeled protein.
Crystallization
We used the hanging drop vapor diffusion method for growing crystals
(McPherson et al., 1995). We used Commercially available crystal screening kits for
screening around >600 different crystal conditions, Crystal Screen I & II, Salt Rx, Index,
Wizard I & II, Nextal Classic L suite, Protein Complex, Additive screen (Hampton
Research screening kits, Qiagen screening kits). Each crystal drop had a total volume of
2µl comprising of 1 µl of 15mg/ml protein and 1µl of crystallization condition. The well
volume was 150µl. I optimized crystallization buffer for its pH, buffer concentration,
additive/precipitant concentration and salt concentration.
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X-Ray data collection and analysis
We flash froze crystals after soaking in a gradient of cryoprotectant solutions. The
gradient soaking follows as: the crystal was first transferred from the crystallization
buffer to a 10% Ethylene glycol containing crystallization buffer, from there to a 5%
glycerol and 15% Ethylene glycol mixture containing crystallization buffer and finally
into a 5% glycerol and 20% Ethylene glycol containing crystallization buffer solution.
We acquired diffraction data using Case Pharmacology X-ray facility and at the Advance
Photon Source at Argonne National Laboratory IL. At Case X-ray facility, the crystal to
detector distance was 80mm. We collected diffraction data at 0.5º oscillation angle
throughout 180º and exposed each frame for 30 sec. Finally, we analyzed our acquired
diffraction data using HKL2000 software.

2.4. Isothermal Titration Calorimetry (ITC)
2.4.1. Overview
ITC has become an invaluable tool in biological sciences and pharmaceutical
industry. We used ITC to understand the energetics of our binding interactions. ITC
measures the associated heat change of an interaction process at constant pressure and is
able to obtain all thermodynamic parameters such as ∆G, ∆H, ∆S, Ka / Kd and
stoicheometry, in one single experiment giving a complete thermodynamic profile of the
binding interaction. ITC can be used with any buffer, at any pH, any solution whether
clear or turbid. Despites its significant advantages, ITC has several drawbacks. One main
consideration is the amount of sample material required for one single experiment. In
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addition, ITC can only measure a heat energy difference of a particular reaction. But
there are reactions which are entropically driven and are not able to detect by ITC.
2.4.2. Design of an ITC experiment
Strong binding < 0.1nM and weak binding > 10nM interactions cannot be
evaluated for its precision and accuracy by ITC. The value of c (c= Ka[M]n) should be
between 1-1000 to perform an accurate experiment with a sigmoidal curve.
When designing an experiment, the ligand and macromolecule, should be in the
exactly same buffer. Control experiments should be performed to evaluate the heat of
dilution of the macromolecule-protein, heat of dilution of the ligand and heat of mixing.
The concentrations of the protein and ligands have to be accurately measured as it
directly correlates with the final results. The choice of buffer is important as certain
buffers containing large molecules (Tris buffer) have a large heat of dilution signal in
which the actual binding signal can be masked. To achieve better sensitivity the choice of
buffer should always be a small ion buffer such as phosphate. Reducing agents like DTT
may cause unstable and noisy baselines which may affect the end-results. Furthermore,
degassing buffers is a very important step as the entrapment of tiny air-bubbles in the
system can contribute to a noisy base-line. Data analysis is performed using ORIGIN 7.0
software which was provided by Microcal Corporation.

2.4.3. Materials and methods
Talin and lipid interaction
We performed a series of ITC titrations between Talin subdomains and PIP2
lipids. I dialyzed Talin proteins of 50µM concentrations overnight into buffer containing
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50mM Sodium phosphate, 150mM NaCl, pH 6.8. The buffers were filtered using a 0.2µ
filter and degassed thoroughly. I suspended the lipids of PIP2 C4 and PIP2 C6 (Echelon)
in the buffer being prepared to a final of 1mM. All experiments were carried out at 298K
with a stirring speed of 300rpm. I performed titrations of a total of 30 injections with an
injection volume of 7.5µl and 4 min spacing time between each injection. Finally, I
collected data on a VP-ITC instrument from Microcal Inc. and analyzed results using
Origin 7.0 software.
Talin and Migfilin interaction
I used a 50µM concentration of Talin F0 for the initial ITC titration experiment. I
dialyzed all protein samples, ligand and macromolecule, overnight into the same buffer of
50mM Sodium phosphate, 100mM NaCl, pH 6.8. The titration was performed on a
ITC200 ultrasensitive micro-calorimeter instrument (Microcal). I performed the titration
between Talin F0 and Migfilin LIM23 in 2µl aliquots of 30 injections. I used a 2mM of
LIM23 as the syringe protein concentration, and analyzed the results using Origin 7.0
software from Microcal.

2.5. Surface Plasmon Resonance Spectroscopy (SPR)
Surface Plasmon Resonance Spectroscopy (SPR) is the most widely used
technique to study and characterize an interaction between two molecules. We used SPR
to understand the binding affinity of a particular interaction, the need of a small sample
size and versatility of the instrumentation and usage. However, the error associated of a
weak interaction and using small molecules is high.
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The basic principle underlying SPR was discovered in 1950s. The phenomenon of
the emission of surface Plasmon radiation at the total internal reflection angle of a light
beam at two density mediums (with one coated with a metal layer) is the basic principle
in SPR. However, the first instrument was developed in the late 1980’s. The intensity of
the emitted surface Plasmon wave is proportional to many factors such as the type of
metal, the thickness of the metal layer and the density of the medium. The mass density
of the medium is utilized in biosensor chip development by immobilizing a wide variety
of ligands.

2.5.1. Materials and methods
We performed all experiments on a BIACORE 3000 (Amersham Pharmacia)
instrument at CCF-LRI Biotechnology core. We used CM5 sensor chips (Biacore) for
most SPR experiments. EDC, NHS and ethanolamine were prepared from the amine
coupling kit (Biacore). I filtered and degassed all buffers though a 0.2µ filter and also
used research grade buffers from Biacore.
Kindlin 2 and Migfilin interaction
We immobilized Kindlin 2 11-143, full length Kindlin 2 and Kindlin 2 1-105 on
CM5 sensor chip flow cells using amine coupling chemistry. Densities reached to 1000
RU during immobilization. We exchanged all ligands to exact buffer as the running
buffer. Ligands used for interaction studies are: Migfilin LIM23, LIM1, LIM2, LIM3,
LIM123 and LIM12. Data collecting was achieved using Biacore control 3000 software
and data analysis was done using BIAevaluation software version 4.0. All experiments
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were done at 25ºC unless otherwise noted. The running buffer used was 50mM Sodium
phosphate, 100mM NaCl, pH 7.0.
Talin and Migfilin interaction
We immobilized Talin F0 and Talin F0F1 proteins on CM5 sensor chip the same
way described above. HBS buffer from Biacore was used as the running buffer. Migfilin
LIM23 and LIM1 proteins were the interacting partners for the experiment.
Kindlin 2 PH domain and PIP3 interaction
I immobilized PIP3 lipids on a L1 sensor chip the same way as described above.
HBS buffer from Biacore was used as the running buffer. Kindlin 2 PH domain (provided
by Dr. K. Fukuda) was used as the interacting partners for the experiment.
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CHAPTER III

KINDLIN 2 N TERMINAL STRUCTURE

3.1. Introduction
Kindlin family proteins play an important role in the human body. The health
related importance of Kindlin 2 was described earlier in chapter 1. Its role in
cardiogenesis as well as in maintaining the homeostasis of adult heart function makes
Kindlin 2 unique among the Kindlin family proteins (Dowling et al., 2008; Hatcher and
Basson, 2008; Orlic et al., 2001). Lack of adequate structural information of Kindlin
family proteins makes us difficult to understand the molecular mechanism of its function.
Kindlin 2 is a relatively novel protein and structural details about Kindlin 2 are hardly
known. However, the F0 domain of Kindlin 1 protein was recently resolved (Goult, B.T.
et al., 2009). This chapter specifically discusses the structural details of Kindlin 2 Nterminal F0 domain.
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3.2. Expression of Kindlin-2 N terminal domains
The requirement of a sub-molar concentration of protein is one of the crucial
factors in protein structure determination. In addition, the stability of the protein at room
temperature for two weeks is another major requirement. Proteins that fall into both
categories are not abundant in vivo. Kindlin 2 is such a cumbersome protein which
required a trial-and-error approach and a subsequent optimization strategy for expression,
yield, solubility and stability of the expressed domains. Lack of information in literature
about the expression conditions of Kindlin variants made us to put an extra effort and
time on getting the protein for structural studies. Our approach was as follows:
1. Choosing boundaries and cloning according to secondary structure prediction and
tertiary model structure prediction of the protein.
2. Checking the instability index, occurrence of rare codons etc of the protein.
3. Optimization for expression
4. Optimization for yield
5. Optimization for protein solubility
Aggregated proteins
Precipitation of the protein
Stability of the protein
6. Back to 1 if none of the approaches succeeded.
Selection of proper boundaries for a protein is the most important step that affects
the final yield and stability of the protein. I selected the boundaries according to the
predicted secondary structure of the protein of interest. In here I chose the boundary so
that it falls into a coiled region of high probability (see Appendix 1).
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Multiple constructs engineered for Kindlin 2 N-terminal and their expression
conditions are shown in table 3.1. Most constructs were challenging in terms of obtaining
the encoded protein in soluble and stable conformation. I carried out an extensive
optimization approach for each construct. Kindlin 2 11-143 was the initial construct
which resulted a soluble protein but yielded less than 1mg per Liter of LB culture. I have
described multiple optimization strategies below which I used to improve the yield of
Kindlin 2 11-143 protein.
A major fraction of the protein accumulated in inclusion bodies. I performed a
protein refolding approach from inclusion bodies for Kindlin 2 11-143 protein. Among
the available methods, we chose refolding via a decreasing percentage of urea
concentrations. I compared the 1H-15N HSQC spectra of the native and refolded

15

N

labeled protein. The spectra were completely different implying that refolding failed for
Kindlin 2 11-143 construct.
There will be always a controversy arisen when a human protein is expressed in a
bacterial expression system. Compared to the easiness of handling, low turn-around time
and recombinant protein expression, bacterial expression systems are always preferred
against eukaryotic expression systems. To avoid or reduce the conflict of proper folding
of the protein we used a chaperone co-expression to assist protein folding. I transformed
different types of chaperone encoding plasmids into the bacterial strains containing our
expression constructs (Takara). A significant increase in the yield of soluble protein
could not be observed for Kindlin 2 11-143 protein.
The codon usage in bacteria is somewhat different from that of Eukaryotic cells.
The relative frequency that certain human codons are used in bacteria is different as well.
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For example a human CCC codon for proline has a 0.4% average frequency been used
per 100 codons compared to other proline encoding codons CCU – O.7%, CCA – 0.8%,
CCG – 2.4%. As a result there will be a pause during translation as the ribosome has to
‘wait’ until it gets the CCC tRNA. If the occurrence of rare codons is high moreover
consecutive, the ribosome may stop translating the protein resulting in a truncated protein
or may allocate a wrong codon. To prevent such incidents there are bacterial expression
systems being introduced which increase the pool of rare codon tRNAs within the
bacteria. E.g. Rosetta, Rosetta2, RIPL etc. Kindlin 2 11-143 has several rare codons. The
expression of the construct in Rosetta 2 bacterial cells did not increase the solubility of
the protein (Burgress-Brown et al., 2008, Pro. Exp. Purifi.).
Another addition for this approach was to synthesize the DNA sequence after
codon optimization. In here the whole DNA sequence of Kindlin 2 11-143 was
synthesized selecting or changing rare codons for more abundant codons in bacteria. I
cloned the cDNA or minigene (IDT, Integrated DNA Technology) into a suitable vector
and analyzed its expression. Results did not show a significant improvement of soluble
protein.
MIG-2
BOUNDARIES
1-134
1-154
1-158
1-218
11-177
11-143

1-105

FUSION
TAG
HIS
GST
HIS
HIS
GST
GST
HIS
GST
GST
MBP
MBP
GST

BACTERIAL
HOST STRAIN
Rosetta 2 (DE3)
Rosetta 2 (DE3)
Rosetta 2 (DE3)
Rosetta 2 (DE3)
Rosetta 2 (DE3)
Rosetta 2 (DE3)
Rosetta 2 (DE3)
BL21(DE3) pLys
Rosetta 2 (DE3)
BL21 (DE3) RIP
BL21(DE3) pLys

PROTEIN
EXPRESSION
+
+
+
+
+
+
+
++
++
+
+
+++

PROTEIN
GEL
SOLUBILTY FILTRATION
insoluble
insoluble
partly soluble Aggregate
insoluble
insoluble
partly soluble
insoluble
soluble
monomer
soluble
monomer
soluble
monomer
soluble
monomer
soluble
monomer

Table 3.1. Summary of Kindlin 2 N-terminal constructs.
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There are endless possibilities to argue to what may be the cause for poor
expression and insolubility and what can be done next. However, two major approaches
were selected and used in this study. First is to subclone a certain region of interest of the
protein cDNA and optimize extensively for its expression, solubility etc. for a soluble
monomeric /oligomeric stable protein. Second is to subclone a large number of constructs
simultaneously varying the boundaries of the protein and check their expression and
solubility. Having attempted both strategies, it is quite evident, that the time spent for
optimizing a protein of a particular construct for endless possibilities is way more time
consuming and not cost-effective than varying the boundaries of the protein.

3.3. The structure of Kindlin 2 N-terminal
To understand the role of Kindlin-2 N-terminal in integrin activation, it is
essential to know the molecular level details about the protein. In order to obtain the
structure in an atomic level resolution of Kindlin 2 N-terminal, we used a two part
approach, NMR and X-ray crystallography for potential structure determination of the
protein. The techniques were described in Chapter II.

3.3.1. Crystallographic approach for Kindlin 2 11-143
We performed crystallization trials for both Kindlin 2 1-105 and 11-143 proteins.
Despite the vast yield difference between the two constructs, <1mg/L of LB culture
media for K2 11-143 and >10mg/L of LB culture media for K2 1-105, we were able to
obtain sufficient protein for initial crystallization setup. A single crystal was obtained for
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Kindlin 2 11-143 protein but Kindlin 2 1-105 protein showed no signs of crystallization
hits so far. Several images of the crystals in different crystallization conditions are shown
in figure 3.1. The Kindlin 2 full length model structure (Fig 3.10.) shows that there is
long floppy overhang at the C-terminus from residues 95 to 105 which might have
prevented tight crystal packing i.e. crystallization. According to the NMR structure of
Kindlin 2 1-105 (next sub-chapter) the N-terminal 1-12 residues show a very dynamic
behavior. This may be another reason to prevent crystallization of Kindlin 1-105 protein.
In contrast, in Kindlin 2 11-143 construct, residues 95 to 143 forms an anti parallel beta
sheet and a small helix at the C- ter which might have helped in better crystal packing
and promoted protein crystallization. The model structure was not present at the time of
choosing domain boundaries for cloning. Having the model structure currently, a much
better construct would be residues 12-95 or 20-95, which reflects the core region of the
Kindlin 2 F0 domain.
We obtained multiple crystallization conditions for Kindlin 2 11-143 protein from
the initial trial. These are:
1. 1.4M sodium potassium phosphate, pH 8.2.
2. 0.1M Tris, pH 8.5, 1.2M sodium potassium tartrate tetrahydrate.
3. 0.1M Tris , pH 8.5, 0.7M tri-sodium citrate dehydrate
All conditions where crystallization has occurred had a pH higher than 8.0. Thus Kindlin
2 11-143 protein crystallization is pH sensitive. We performed optimization around the
crystallization condition for pH, salt concentration, temperature and buffer concentration.
The best crystallization condition was 1.6M sodium potassium phosphate at pH 8.2.
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(a)

(c)

(b)

(d)

(e)
Figure 3.1. Protein crystal images of Kindlin 2 11-143. (a), (b) and (d)
grown in 1.4 M sodium potassium phosphates, pH 8.2. (c) protein crystal
was grown from 0.1M Tris, pH 8.5, 1.2M sodium potassium tartrate
tetrahydrate. And crystal (e) in 0.1M Tris, pH 8.5, 0.7M tri-sodium citrate
dehydrate.
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Further optimization using the additive screen kit for the optimized condition revealed a
0.1mM of spermidine as the additive constituent. Crystal cryoprotection was achieved
through a sequential gradient of quick soaks explained in the experimental section of
chapter 2.3.

Figure 3.2. Diffraction pattern of Kindlin 2 11-143 protein crystal. The
diffraction patterns on other oscillation angles show severe overlap. The
crystal is diffracting to 3.0 angstrom resolution, but the 3D structure could
not be resolved due to severe spectral overlap.

An image of the diffraction pattern of Kindlin 2 11-143 protein crystal is shown in
figure 3.2. We collected images at 0.5º oscillation angles. A severe overlap was seen
among most consecutive images. We analyzed the data by HKL2000 software and the
initial analysis revealed that the crystals diffracted to 2.9 Å resolutions with a space
group of p21212. We were not successful in the structure determination process due to
severe overlap of data points. Data analysis from both in-house x-rays and synchrotron
light source failed due to severe peak overlap of reflections.
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A future approach would be 0.25º oscillation angle image collection with an
increase in detector distance. This may expand the peak positioning on the film and may
prevent the peak overlap. However, due to the very low yield of the protein and
difficulties in reproducibility, crystallization setup for Kindlin 2 11-143 was not
convenient.

3.3.2. NMR structure of Kindlin2 N-terminal 1-105
Kindlin 2 1-105 protein is stable even for weeks at room temperature. I was able
to concentrate the protein up to 2mM without any signs of precipitation. We used a one
milli-molar of 15N and 13C doubly labeled sample for structure determination. The 15N-1H
HSQC spectrum shows excellent chemical shift dispersion with uniform signal intensities
suitable for detailed NMR studies.
We selected peaks prior resonance assignment, using NMRview software. We
first selected peaks of the HSQC spectrum, followed by selecting peaks in triple
resonance spectra HNCACB and HNCACO. Residues 8 and 68 are overlapping in the
HSQC spectrum. Another cluster of overlapping residues in HSQC spectrum was
observed for residues 25, 42 and 66. HNCACB, HNCA and CBCACONH were
comparatively analyzed for confirmative peak picking in HNCACB spectrum. Similarly
HNCACO and HNCO spectra were comparatively analyzed for peak picking in
HNCACO spectrum. There were difficulties in 100% resonance assignment of HNCACB
and HNCACO spectra due to overlap of resonances but more than 95% residues were
assigned.
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Figure 3.3. 1H-15N HSQC spectrum of Kindlin 2 1-105. The peaks are
labeled with the corresponding assignment of Kindlin 2 1-105 residues

48

Backbone assignment We used PASA, a software for automatic backbone
assignment, for backbone assignment (Xu et al., 2006). The chemical shift tables of
HSQC, HNCACB and HNCACO spectra were used as the input for PASA. We
completed all ambiguous assignments manually. 88% of the backbone assignment was
completed (99/112 residues). There are 9 missing peaks: 4 proline residues and residues
33, 60, 61, 62, 75 which were unable to assign. The assigned HSQC spectrum is shown in
figure 3.3.
We calculated the secondary structure of the protein from the C α and C β
chemical shifts obtained from assigned spectra listed above. The secondary structure
prediction shows that the protein comprises of a combination of helices and beta sheets.
The prediction is shown in figure 3.4. An extended helix is observed between residues
46-58 and a short helix is predicted from the chemical shift indices between residues 8589. Beta strands are predicted between residues 24-30, 36-43, 67-73 and 96-100.
Side chain assignment was not 100% complete. We were able to assign
approximately 85% of the peaks from both HC(CO)NH and C(CO)NH spectra. Most of
the peaks were missing and some show severe overlap. A stretch of alternative long side
chain amino acids leucines and arginines showed missing and overlapping spin systems.
HCCH-TOCSY spectra were helpful in assisting in side chain assignment of the protein.
The 3D structure We calculated the 3D structure as described in section 2.1.3.
The N-ter Kindlin 2 1-105 structure has an ubiquitin-like beta-grasp fold, similar to
Kindlin 1 structure. A 12 residues long alpha helix (residues 48-59) is partly surrounded
by 5 beta sheets of variable lengths. The solution structure is shown in Figure 3.5 and was
calculated from a total of 1304 restraints. The table of structural statistics for the solution
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structure is shown in table 3.2. The structured core represents residues 16-93
(corresponding to residues 23-100 in our structure) has a convergence of 0.4Å.

Figure 3.4. Secondary structure predictions of Kindlin 2 1-105.Chemical
shift indices correspond to 13Cα and 13Cβ spin resonances of each residue.
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The N-terminal 1-18 residues of Kindlin 2 1-105 structure shows a helical feature
spanning residues 6-12 (13-19res in our construct) which we defined by a distinct set of
NOEs. A beta hairpin is seen within residues 25-42, with β1 from residue 25-31 and β2
from residues 36-42. Hydrogen bonds were observed between 25-42, 27-40, 29-38 and
31-36 residues. The turn is defined by 4 residues in which residue Asp 33 is a missing
spin system. The first helix, α1 is 12 residues in length (res 48-59). Residues 60-62 are
missing spin systems. The loop from residue 59 to 69 is less defined due to the missing
stretch of spin systems. Residues 69 to 71 and 77-79 form short beta strands β3 and β4
respectively. The fifth beta strand β5, defined by residues 98-100, runs in-between β1
and β3 with hydrogen bond contacts to both β1 and β3 strands. These strands form a beta
sheet which covers the hydrophobic side chains of the α1 helix.
The Ramachandran plot is shown in figure 3.6, which is a sum of 20 low energy
structures out of 100 structures. 96.4% of residues between 8-101 residues of Kindlin 2
F0 domain structure belong into the category of allowed region in the Ramachandran
plot. The missing spin systems, residues 33 and 60 on the plot are violated among all 20
calculated low energy structures in the Ramachandran plot. Structural statistics for the
low energy 20 structures are shown in table 3.2. The overlay of the 100 lowest energy
structures is shown in figure 3.7. This figure show high convergence of the structures
between residues 23-100. However the N-terminal tail residues 8-23 display a dynamic
behavior.
Overall, Kindlin 2 F0 domain structure is in excellent agreement within the
quality parameters for NMR solution structure calculation.
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90º

Figure 3.5. A ribbon diagram of the structure of Kindlin 2 1-105. The α
helices are depicted in cyan color and the beta strands in magenta. The
structure shows 2 distinct helices spanning across residues 48-59 and 86-89.
A helix like feature is apparent in the N-terminus across residues 15-19.
Five beta strands with varying length partially covers α1 helix.
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parameters
NOE distance restraints
All

1304

Sequential, │i-j│=1

436

Medium range, 1<│i-j│<6

222

Long range, │i-j│>= 6

295

Intraresidue

445

RMSD from idealized covalent geometry
Bonds (Å)

0.0057 +/- 0.0001

Angles (deg)

0.6873 +/- 0.0181

Impropers (deg)

0.5258 +/- 0.0124

Total energy (kcal/mol)

811.28

Ramachandran plot
Most favored region (%)

69%

Additionally and generously allowed region (%)

31%

Disallowed region (%)

0%

Average RMSD residues 8-100
Backbone atoms (Å)

1.745 +/- 0.470

Heavy atoms (Å)

2.087 +/- 0.418

Average RMSD residues 23-100
Backbone atoms (Å)

0.425 +/- 0.105

Heavy atoms (Å)

1.002 +/- 0.125

Table 3.2. Structural statistics of Kindlin 2 1-105 structure calculation.
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Figure 3.6. Ramachandran plot of Kindlin 2 1-105 of the 20 lowest energy structures.
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Figure 3.7. The overlay of the 100 lowest energy structures.

Figure 3.8. Surface representation of the charges of the structure of Kindlin 2 1-105.
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3.4. Structural comparison of Kindlin 1 and Kindlin 2 F0 domains.
Kindlin 1 and 2 full length proteins share 62% sequence identity. The N-term
residues 1-105 including the F0 domain of both proteins have a sequence similarity of 62
%. Figure 3.13.(a) shows a sequence comparison between all N-term 1-105 sequences of
Kindlin proteins.
A closer look at the multiple sequence alignment of Kindlin proteins show a
considerable similarity between residues 18-105 among all three sequences. The core
structure is well conserved among Kindlin F0 domain within orthologs (Goult et al.,
2009).

A considerable difference is seen within the first 18 residues of Kindlin 2

compared to the first 11 residues in Kindlin 1 and the first 16 residues in Kindlin 3.
These sequences are drastically different in length and composition compared to the core
structure and might account for potential differences in binding patterns.
The N-terminal 1-18 residues show a right handed helical feature spanning
residues 6-12 (13-19 residues in our construct). This feature is not present in Kindlin 1
structure, in which the corresponding region is disordered. In addition to the helical
feature in the N-terminus, there are two other significant differences between Kindlin 1
and 2 structures: First is the turn between β1 and β2 strands. In Kindlin 2 it is a tight turn
of four residues whereas in Kindlin 1 it comprise of nine residues. See figure 3.9.(b). The
assignment of residue D33 in the turn of Kindlin 2 is missing. The helices α1 and α2 have
equal lengths in Kindlin 1 and 2 F0 domain, which are 13 and 5 residues respectively.
Both helices are right handed with similar orientation angles. The second major
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(a)

(b)
Figure 3.9. (a) Multiple sequence alignments of residues 1-105 of Kindlin
proteins. K1=Kindlin 1, K2=Kindlin 2, K3=Kindlin 3. The sequence alignment
was obtain using Clustal W software, which is the most commonly used softare
for the alignment of multiple residues. (b) Overlay of Kindlin 1 and 2 solution
NMR structures. Blue-Kindlin 1 and red-Kindlin 2 F0 domains. Despite the 60%
sequence similarity, the globular fold is the same. Minor differences are observed
between the two structures.
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difference between Kindlin 1 and 2 F0 structures is the length and position angle of the
beta strands. β1 and β2 beta strands in Kindlin 1 and 2 have equal lengths and
orientations except the beta hairpin turn, which is different in the number of amino acids.
In Kindlin 2 F0 domain, the β3, β4 and β5 strands are slightly different in orientation
angles and lengths compared to Kindlin 1 F0 domain. Minor differences between the two
structures may account for the functional differences between the F0 sub-domains of the
two proteins.

3.5. A Model 3D structure for full length Kindlin 2 protein.
Kindlin 2 is a relatively novel protein, which has not been studied extensively
although it plays a significant role in homeostasis. Neither its structural details nor
structure based functions have been reported so far making it difficult to evaluate its
function at a molecular level. The current information available on the full length Kindlin
2 protein is its primary sequence and its predicted secondary structure. It is difficult to
understand the potential function of Kindlin 2 merely from its primary and secondary
structure. A tertiary structure of a protein gives much more insight to its function.
Determining the tertiary structure of a protein is a complex process which requires time
and expertise skills. Generating or predicting model 3D structures from the protein
sequence has become a common task. Model structures give insight to the structure, may
help us to understand its function/potential function and assist in designing projects
accordingly. With the increasing availability of free accessible web servers and fast
computers, obtaining model structures for proteins is nowadays a common task.
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Robetta/Rosetta and i-Tasser are few of those widely used servers for computer generated
prediction of model structures from the primary protein sequence.
To have a better view on the full length Kindlin 2 protein, we obtained a model
structure from Robetta protein structure prediction server at http://robetta.bakerlab.org.
The full length amino acid sequence residues 1-680 of Kindlin 2 was submitted to the
server for automated structure prediction. The server uses comparative modeling and de
nova structure prediction methods to create subdomain models, which are pooled together
to create the lowest energy models structures. (Kim et al., 2004). Several lowest energy
model structures were generated and are shown in Figure 3.10. All structures show
similar domain structures but slightly different orientations. These models show a
multiple domain globular fold structure. The putative PH domain is surrounded by other
domains of Kindlin 2. The F2 subdomain is split by the PH domain which is consistent in
all model structures and comparable with literature. The bipartite F2 and F3 show tight
packing against the PH domain. The model structure shows close proximity between the
Kindlin 2 F0 domain and F2 subdomain.
Model 1 is the lowest energy structure. We are interested to understand which of
these models may be the closest to the accurate structure. Dr. Koichi Fukuda, a member
in our laboratory, was able to obtain Kindlin 2 PH domain protein and kindly provided it
for my experiments. The only two subdomain proteins of Kindlin 2 available are the F0
and the PH domain. The proximity of the PH and F0 domain is different in each model
structure and we questioned whether there is an interaction between the two subdomains.
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(a)

(b)

(c)

(d)

(e)
Figure 3.10. Lowest energy model structures for Kindlin 2 Full length
protein predicted from the Robetta server. (a) Model 1 (b) Model 2 (c)
Model 3 (d) Model 4 (e) Model 5. Blue-F0 domains yellow and red-F1
domain, Cyan and magenta- F2, green- PH domain and grey-F3
subdomain.
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To evaluate whether there is an intermolecular interaction between F0 and PH
domain, we performed a HSQC NMR experiment. The HSQC spectra were recorded for
0.1mM 1H-15N Kindlin 2 1-105 and in the presence of 0.2mM Kindlin 2 PH domain. The
superimposed spectra are shown in Figure 3.19 and display no significant peak
perturbations. This implies that the interaction between PH domain and F0 domain is not
significant. Observing all the model structures we excluded the possibility that model 1 is
precise since the PH domain and the F0 domains are in close contact in model 1 structure.
It leaves us with the possibility that model 2-5 may be close to the actual structure of
Kindlin 2. However, it could also be reasoned that although spatially close there might be
no significant interaction between Kindlin 2 F0 and PH domains.

3.6. Summary of chapter 3 results.
To summarize, Kindlin 2 1-105 solution structure is the first piece of atomic level
information obtained for Kindlin 2 protein. The difficulty of getting soluble and high
yielding protein for the full length protein and its subdomains slows down structural and
functional analyses.

Despite the 60% sequence similarity, Kindlin 2 1-105 structure

adopts a similar fold to Kindlin 1 1-95 structure. The fold of both proteins is an ubiquitinlike beta grasp fold with a 10 residues long alpha helix which is surrounded with 5 beta
strands. The solution structures of Kindlin 1 and 2 N terminal F0 domains show minor
differences from each other and these structural differences may be useful to relate them
to their potential function/s.
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Figure 3.11. 1H-15N HSQC spectra of 15N Kindlin 2 0.1 mM 1-105 in the
absence (black) and presence (red) of 0.2mM Kindlin 2 PH domain
showing no interaction of 15N Kindlin 2 1-105 and Kindlin 2 PH
domain.
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CHAPTER IV

INTERACTIONS OF KINDLIN 2 F0 DOMAIN

4.1. Overview
The function of a protein is related to its three dimensional structure of the
protein. We have solved the solution structure of Kindlin 2 F0 domain. Kindlin 1 and 2
F0 domains share > 60% sequence homology and adopts a similar 3D fold. It could be
assumed that the functions of the Kindlin 1 and 2 F0 domains are similar. However, the
function of Kindlin 1 F0 domain (Goult, B. T., 2009) has not been elucidated up-to-date.
Having the structure the next step is to understand the function/s of the F0 domain.
This chapter describes several binding interactions of Kindlin 2 F0 domain. Altogether,
we suggest a potential role of Kindlin 2 F0 domain in the process of integrin activation.
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4.2. Kindlin 2 N-terminal – a domain essential for Kindlin and Talin mediated
integrin activation
The N-ter region of Kindlin 2 is known to interact with ILK and Migfilin (Tu et
al., 2003). However the role of the F0 domain of Kindlin 2 has not been functionally
characterized and there is no information in literature about the function of Kindlin N
terminal or F0 domain.
Kindlin proteins (in particular the C terminal FERM domain) bind to integrin β
CT and play a cofactor role in integrin activation (Goult et al., 2009; Harburger et al.,
2009; Larjava et al., 2008; Ma et al., 2008; Montanez et al., 2008; Moser et al., 2009). To
understand whether there is a functional significance of Kindlin 2 F0 domain in integrin
activation, an integrin activation assay was performed in collaboration with Dr. YangQing Ma in Dr. Ed. Plow laboratory.
In here, a particular focus was given to compare the effect of the full length
Kindlin protein and F0 domain deleted full length Kindlin 2 in integrin activation. We
transferred the corresponding constructs into EGFP vectors. The constructs were
transfected into CHO cells, which stably express αIIbβ3 integrins. Activation of integrins
was measured based on PAC1 binding, an antibody which only binds to activated
integrins. To understand the role of Kindlin 2 in Talin induced integrin activation, TalinH-EGFP constructs were co-transfected to CHO cells. Talin H domain is a considerably
stronger co-activator of integrin than full length Talin (Goksoy et al., 2008).
The data summarized in Figure 4.1. are results from 3 independent experiments
showing that there is more than a two fold activation of integrins in the presence of
Kindlin 2 compared to Talin H alone. Integrin activation with Kindlin 2 alone shows a
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much weaker activation than Talin H alone (Ma et al., 2008). By comparison, there is a
substantial decrease in integrin activation in residues 11-143 deleted Kindlin 2 construct.
The same was true for 1-105 deleted Kindlin construct (data not shown). Previous studies
have indicated that Kindlin-2 1-263 was important for integrin activation but now we
further narrowed down to 1-105 region. These data have highlighted the importance of
Kindlin N-ter in integrin activation. Further it is evidenced that Kindlin F0 plays a central
role in integrin activation.

7

Integrin activation (MFI)

6

5

4

3

2

1

0
vector

talin-H

talin+K2

talin+K2∆N11143

Figure 4.1. The effect of Talin head domain, Talin head - Kindlin 2 and
Talin head – Kindlin 2  11-143 in integrin activation. CHO cells which
are stably expressing αIIbβ3, were transfected with cDNAs of Talin head
domain, Talin head- Kindlin 2 and Talin head – Kindlin 2 ∆ 11-143. The
EGFP positive cells were gated and used to monitor PAC-1 binding/integrin
activation (Ma et al., 2008).
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4.3. Kindlin 2 N-ter and integrin interaction
Knowing the structure of Kindlin 2 1-105 and its functional significance in vivo,
we questioned the role of Kindlin 2 N-ter in integrin activation. There is evidence from
literature for direct interaction of Kindlin 2 C-ter with integrin (Shi et al., 2007; Ma et al.,
2008; Bledzka et al., 2010). Deletion of Kindlin 2 1-218 or 1-345 from full length
Kindlin disrupts the interaction with integrin CT (Ma et al., 2008). To investigate whether
Kindlin 2 F0 domain (1-105 residues) interact with the integrin CT, we performed a
series of experiments using NMR. HSQC-NMR is the most simple, quick, informative
and straightforward experiment to examine the interaction between two proteins.
Integrin CT peptide residues K716-T764, has been widely known for its low
solubility at physiological salt concentration. Thus, the wild type peptide is difficult to
use for NMR experiments with Kindlin proteins as the stabilizing buffer is 50mM
Sodium phosphate and 100mM Sodium Chloride. Several modifications on the CT have
been done to improve solubility and stability of the peptide (Goksoy et al., 2008;
Wegener et al., 2007). One such modification from one of our group members, Dr.
Jianmin Liu, was to mutate several N terminal hydrophobic membrane proximal Leucine
residues. This has dramatically improved the stability and solubility of the peptide.
Figure 4.2 shows the HSQC of two superimposed spectra, the HSQC of 0.1 mM
15

N-D β3 integrin mutant CT in the presence of 0.2mM Kindlin 2 1-105 in red and in

black the free form (15N-D β3 mutant). Several peaks have been shifted giving direct
evidence for interaction between the two molecules. The same peaks have perturbed for
Kindlin 2 11-143 interaction (data not shown). Mapping the perturbed residues on
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Figure 4.2. 1H-15N HSQC spectrum of integrin 15N-D β3mutant CT and
Kindlin 2 1-105 interaction. An overlay of the 1H-15N HSQC spectra of β3
integrin CT mutant (in black) and β3 mutant in the presence of Kindlin 2 1105 (in red) at 1:2 molar ratio.

integrin revealed that the very N-terminal stretch of residues and several residues in the
linker region are involved in the interaction (Shown in Figure 4.3.).
The reverse NMR experiment of

15

N Kindlin 2 1-105 and unlabelled β3 integrin

CT mutant was performed at a 1 to 2 excess molar ratio. Data shown in Figure 4.4
suggests a very weak interaction with small peak shifts. β3 integrin CT wild type His
fusion protein and β3 integrin wt MBP fusion protein have a similar peak perturbation
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pattern (data not shown). The perturbed residues on Kindlin 2 1-105 are shown in Figure
4.3.

GSSHHHHHHS SGLVPRGSHM 716KKKITIHDRK EFAKFEEERA
AKWDTANNP LYKEATSTFT NITYRGT
Figure 4.3. Perturbed residues of integrin CT sequence. The linker
region is underlined. The β3 CT starts with

716

K. The stretches of

716KKKITIH and GLVP in the linker are essentially perturbed by Kindlin 2
1-105 interaction highlighted in red.

Although very weak, these data suggest that Kindlin 2 1-105 may be partially
involved in binding to integrin (in addition to the major binding site by Kindlin-2 Cterminal PTB domain).

The full structure of Kindlin-2 is not available, however,

examination of the model structures suggest that the N- and C-terminus of Kindlin-2 are
spatially close (Fig 3.10) so integrin β3 CT might bind to both regions. Such binding
mode may enhance the tighter association of Kindlin 2 with integrin.
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Figure 4.4. 1H-15N HSQC superimposed spectra of 15N Kindlin 2 1-105
and unlabeled β3 integrin CTmutant interaction. The red peaks
correspond to

15N

Kindlin 2 1-105 in the presence of β3 CT at 1:2 molar

ratio. The black peaks correspond to 15N Kindlin 2 1-105 HSQC spectrum.
The peaks shifts are observed at 1:2 excess molar ratio are small but
consistent among repeated experiments.

Figure 4. 5. Ribbon diagram of Kindlin 2 1-105 highlighting perturbed
residues due to integrin interaction. The most perturbed peaks are
confined to one area of the molecule.
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4.4. Kindlin 2 N’ and membrane interaction
As revealed above, functional data show that Kindlin 2 1-105 plays an important
role in integrin activation and in vitro NMR data supports that integrin CT interacts with
Kindlin 2 F0 domain. The membrane N-ter residues that have perturbed belong to the
very proximal residues of the integrin beta3 CT. For such interactions in vivo, Kindlin 2
F0 domain should come in close contact with the membrane. We reasoned whether there
is a secondary interaction between the membrane and Kindlin F0 which may help to
stabilize the interaction between Kindlin F0 and integrin.
To investigate our hypothesis, we used NMR as our tool for analysis. In order to
create a membrane mimetic environment, LUV, large unilamellar vesicles of
phosphoinositides with 25% PIP2 were provided from one of our group members, Dr.
Jun Yang. These form the necessary membrane surface for analysis. We added LUV at
1:5, 1:10 and 1:20 molar ratios to 15N labeled Kindlin 2 1-105 protein and HSQC spectra
of Kindlin were recorded in the presence and absence of LUV’s. Data are shown in
Figure 4.6 reveal a weak interaction between the membrane and Kindlin F0 even at low
molar ratio.
This piece of information confirms that Kindlin 2 F0 domain interacts with the
membrane weakly. This supports our hypothesis that Kindlin 2 F0 may stabilize the
interaction between integrin and Kindlin F0 by tethering to the membrane. As mentioned
above, Kindlin 2 also contains a PH-like domain that may bind to phosphoinositides to
facilitate the kindlin-2/membrane association. Our collaborator Cary Wu has recently
found that Kindlin 2 does potently bind to PIP3 and such binding seems to be important
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for Kindlin 2 mediated integrin activation (Qu et al., submitted). I therefore measured the
Kindlin 2 PH

(a)

(b)

(c)

(d)
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(e)
Figure 4.6. 1H-15N HSQC spectra showing interaction of

15

N Kindlin 2

1-105 and LUV/PIP2. (a) An overlay of spectra of black – free form of
Kindlin 1-105, red – complex of Kindlin 2 1-105 and LUV at 1-5 molar
ratio, green – complex of Kindlin 2 1-105 and LUV at 1-10 molar ratio, blue
- complex of Kindlin 2 1-105 and LUV at 1-20 molar ratio. (b) and (c)
zoomed images of (a). (d) is the 1H-15N HSQC of the interaction between
Kindlin 2 1-105 and PIP3(C16). (e) Ribbon diagrams Kindlin 2 1-105
representing and highlighting perturbed residue side chains due to
membrane interaction in green and PIP3 interaction in pink.

domain, (kindly provided by Dr. Koichi Fukuda) binding to PIP3 using SPR experiment,
which revealed the Kd~1µM (Appendix 5). Thus, Kindlin 2 may use its multiple domains
including F0 and PH-like domain to associate with membrane to facilitate the Kindlin2/integrin interaction. Structural and functional analysis of filamin/integrin complex
(Kiema et al., 2006) showed that filamin is a negative regulator of integrin activation.
Interestingly, the filamin binding site on integrin seems to mask both Talin and Kindlin 2
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binding (Figure 4.7.). Thus, one possible mechanism for the co-activation of Kindlin 2
and Talin is that they both compete with Filamin and promote the integrin activation. The
membrane association of Kindlin 2 may tether the Kindlin 2 binding to integrin tail to
enhance the kindlin-2 effect (Figure 4.7.).

Talin

Filamin

Kindlins

Figure 4.7. Integrin beta CT sequences showing Talin, Filamin and
Kindlin binding sites. Filamin binding site on integrin partially overlaps
with Kindlin PTB and talin binding sites (slide adopted from Dr. Mitali
Das).

4.5. Summary of chapter 4 results
To summarize, as described throughout the chapter, Kindlin 2 F0 domain plays a
significant role in integrin activation. Deletion of F0 domain abolished the contributory
effect in Talin induced integrin activation due to full length Kindlin 2. Thus F0 domain
itself plays a very important role in integrin activation. How F0, PH and F3 domains
cooperate in integrin activation needs to be further investigated at atomic level.
From binding interaction studies Kindlin 2 F0 domain interacts with PIP2/membrane and
integrin β3 CT tails. Interestingly the interaction sites or residues of Kindlin 2 F0 domain
are non-overlapping.
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CHAPTER V

INTERACTIONS STUDIES OF KINDLIN 2 AND MIGFILIN

This chapter addresses aim 3. The role of Kindlin 2, together with its potential
interacting partners, is evaluated in the complex process of integrin activation. The first
section (5.1.) investigates the interaction between Kindlin 2 and Migfilin. A detail
analysis of Kindlin 2 and Migfilin interaction/s is evaluated to understand its role in the
focal adhesion complex. The second section (4.2.) investigates the global role of Migfilin,
Kindlin 2 and Talin H in integrin activation.

5.1. Kindlin 2 and Migflin interaction – a necessary link in focal adhesions.
5.1.1. Introduction
It has been shown in literature that Kindlin 2 interacts with Migfilin (Tu et al.,
2003; Wu, 2005). The interaction between Kindlin 2 N-ter and Migfilin is required to
recruit Migfilin to focal adhesion site (Tu et al., 2003). Based on our model of integrin
activation (Chapter 1, Figure 1.6.), the recruitment of Migfilin is a necessary step for the
removal of bound Filamin from the integrin β CT. The accessibility of integrin CT for
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binding is the most important and initial step in the process of integrin activation.
Migfilin N-terminal 1-36 residues bind to Filamin, removing Filamin from the CT. At
resting/inactive states of integrins Filamin is bound to integrin CT and masks Talin H and
Kindlin 2 binding sites on the integrin tail demonstrating the negative regulatory effect of
Filamin in integrin activation (Kiema et al., 2006; Ithychanda et al., 2009a and b; Wu,
2005). Removal of Filamin from integrin allows Talin H and Kindlin to bind to CT and
promote subsequent activation of integrins (Chapter 1, Figure 1.6).
Based on the facts in literature, (a) Kindlin 2 plays a role in recruiting Migfilin to
focal adhesion site and (b) Kindlin 2 may also play a role in integrin activation. It is not
clear how Kindlin performs both these functions. As the initial step of understanding the
central role of Kindlin 2 in the complex process of integrin activation, we investigated the
interaction between Kindlin 2 N-terminal and Migfilin. To pinpoint the binding surfaces
and further understand the role of Kindlin 2 N-terminal sequences we initiated to
investigate the interaction between Kindlin 2 and Migfilin using Kindlin 2 F0 domain
protein as a starting point. The following sub-chapter provides an outline of the
experiments and results of the binding interactions of Kindlin 2 and Migfilin.

5.1.2. Kindlin 2 N-ter and Migflin interaction
The interaction between Kindlin 2 and Migfilin is mediated through the LIM
domains of Migfilin (Tu et al., 2003). Unpublished in vivo data from our collaborator, Dr.
Cary Wu, show that the interaction is abolished upon deletion of residues 1-218 of
Kindlin 2. This demonstrates that Kindlin 2 N-terminal region is responsible for the
interaction between Kindlin 2 and Migfilin.
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The N-term region of residues 1-218 of Kindlin 2 mainly comprises of the F0 subdomain and partial F1 sub-domain. As a starting point, to investigate the interaction
between Kindlin 2 and Migfilin, we speculated whether there is an interaction between
Kindlin 2 and Migfilin via the N-terminal 1-105 residues (F0) of Kindlin 2 and LIM
domains of Migfilin. We used NMR as our tool for initial analysis.
We cloned Migfilin LIM domains separately and in all possible combinations into
pHis-1 and pGEX-4T-1 vector. These are: Migfilin LIM123, LIM23, LIM12, LIM1,
LIM2 and LIM3. All His fusion tag constructs were completely insoluble. The GST
fusion proteins were soluble and further optimization revealed that 15 º C inductions gave
a very high yield of soluble protein. Figure 5.1 shows the HSQC spectra of all LIM
domain proteins of Migfilin. The spectra of LIM1 and LIM2 proteins show well spread
peak distribution implying a properly structured protein. Surprisingly, the peaks of the
HSQC spectrum of Migfilin LIM3 are confined into a narrow range around 8ppm of the
1

H-scale. This demonstrates that LIM3 is an unstructured protein. More interestingly, the

HSQC spectrum of LIM23 domain does not show peak crowding around the center 8ppm
(see figure 5.3.(e)). The spectrum of Migfilin LIM23 shows almost a twice as much of
peaks compared to LIM2 domains itself. This shows that LIM3 domain adopts a
structured fold in the presence of LIM2 domain. Therefore all experiments were carried
out using Migfilin LIM23 domain instead of LIM2 and LIM3 separately.
To investigate the potential interaction between Kindlin 2 1-105 and Migfilin
LIM domains we performed a series of 1H-15N 2D HSQC experiments. HSQC is the most
sensitive experiment, which is able to detect interactions between wide ranges of binding
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(a)

(b)

(c)
Figure 5.1. 1H-15N HSQC of all Migfilin LIM domains. (a) shows the
HSQC spetrum of Migfilin LIM 1 domain (b) of Migfilin LIM2 domain
and (c) of Migfilin LIM 3 domain respectively. (a) and (b) spectrums
show a distribution of peaks which correlates to a well folded protein
whereas in (c) spectrum most peaks are centered around 8 ppm which
implies a partially unstructured protein.

affinities from milli molar to nano molar. To initiate the experiments I added an
unlabeled Migfilin LIM23 domain protein into

15

N labeled Kindlin 2 1-105 protein at a

1:2 molar ratio. Each peak in the HSQC spectrum for Kindlin 2 1-105 corresponds an
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amino acid in the protein, more precisely each peak in the HSQC spectrum reflects a
correlation between amide proton and directly attached

15

N group of the protein. Any

change in peak position, peak broadening or peak disappearance of Kindlin 2 1-105
HSQC spectrum upon adding the interacting partner Migfilin LIM23, resembles a change
in the chemical environment of the residue. This implies an interaction between the two
interacting partners. Our assumption was that if there is any interaction between Kindlin
2 1-105 and Migflin LIM23 proteins, it should reflect as peak perturbations or peak
broadening or disappearances in the HSQC spectrum. The recorded HSQC spectrum is
shown in figure 5.2. No significant peak perturbations were observed between Kindlin 2
1-105 and Migfilin LIM23 / LIM1 domains at 1-2 molar ratios suggesting no interaction
between Kindlin 2 1-105 and Migfilin LIM 23/1 domains.
To further confirm our conclusion we performed a series of NMR experiments by
performing the reverse experiments. I recorded HSQC experiments of

15

N labeled

Migfilin LIM1 and LIM23 in the presence and absence of unlabeled Kindlin 2 1-105
protein. The superimposed spectra were evaluated for peak position changes. These data
show no significant peak perturbations, confirming that there is no interaction between
Kindlin 2 1-105 and Migfilin LIM domains.
To summarize, NMR data from figure 5.2., reveal that there is no interaction of
the first 105 residues of Kindlin 2 and Migfilin LIM domain. However, in vivo assays
have shown a strong interaction between Kindlin 2 1-218 (data not shown) and Migfilin
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(a)

(b)
Figure 5.2. 1H-15N HSQC of Kindlin 1-105 and Migfilin LIM domains.
(a) Interaction between

15

N labeled Kindlin 2 1-105 and unlabeled

Migfilin LIM23 domain. (b) Interaction between

15

N labeled Kindlin 2 1-

105 and unlabeled Migfilin LIM1. Both spectra show no significant peak
perturbation implying no significant interaction between the proteins.
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LIM domains. Therefore, we assume that the interacting site between Migfilin and
Kindlin 2 is beyond residues 105 of Kindlin 2.
To evaluate the effect of the residues between 105 and 218 of Kindlin 2 on the
interaction with Migfilin LIM domains, we engineered a number of protein expression
constructs beyond this region. All these constructs were engineered carefully selecting
boundaries according to the model structure of Kindlin 2. The constructs details, their
expression and solubility are summarized in table 3.1. Most of the constructs within 105218 of Kindlin 2 had either low expression of the target protein or the expressed protein
was in the insoluble fraction of the cell. Kindlin 2 11-143 construct had a low expression
and a yield of <1mg per Liter of LB culture. The

15

N labeled protein yield was even

lesser but we are able to obtain a sufficient amount for NMR experiments by growing
cultures in larger scales. To test our hypothesis, a series of HSQC experiments were
performed using

15

N labeled Kindlin 2 11-143 and Migfilin LIM23 domains and vive

versa. The results are shown in figure 5.3.
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(a)

(b)

(c)

(d)
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(e)

(f)
Figure 5.3. 1H-15N HSQC between Kindlin 2 11-143 and Migfilin Lim23
at 1:2 molar ratios. All experiments were performed at pH 6.89 in 50mM
sodium phosphate and 100mM Sodium chloride. Spectrum (a) shows the
interaction between 15 N labeled Kindlin 2 11-143 and unlabeled Migfilin
LIM23 domains. Spectrum (b), (c) and (d) are zoomed images of (a). (e)
Shows the reverse experiment using

15

N labeled Migfilin Lim23 domain and

unlabeled Kindlin 2 11-143 protein. (f) Ribbon diagram of Kindlin2 1-105
highlighting some perturbed residues (23-25 and 83-85 residues) due to
Migfilin LIM23 interaction. The HSQC spectra of Kindlin 2 1-105 and 11143 are not 100% overlapping.
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The spectrum shown in 5.3.(a) and zoomed images (b), (c) and (d), clearly show
significant peak perturbations. A 1:1 molar ratio interaction perturbed the same peaks as
in 1:2 but to a lesser extend. Thus the interaction occurs in a dose dependant manner.
This clearly evidences weak interaction between Kindlin 2 11-143 and Migfilin LIM23
fragments with a weak affinity between the two molecules.
The HSQC spectra of Kindlin 2 11-143 and 1-105 are different. However there
are some peaks that are overlapping. We correlated some of the perturbed peaks to
Kindlin 2 1-105 structure. We could clearly see, as shown in Figure 5.3.(f), that peak
clusters of residues 23-25 and 83-85 are perturbed.
To investigate whether Migfilin LIM1 has an effect (in addition to LIM23) on the
interaction between Kindlin 2 11-143 and Migfilin LIM domains, we cloned all LIM
domains (LIM123) into pGEX-4T-1 vector. Although the expression was reasonable, the
protein was unstable and tends to precipitate during the purification process. We were
unable to obtain a sufficient amount to perform NMR experiments. However, Migfilin
LIM 1 itself is a stable protein. Next, we were interested to understand whether LIM 1
domain of Migfilin has a contributory effect for the interaction between Migfilin and
Kindlin 2 11-143. The HSQC spectrum of 15N Kindlin 2 11-143 and that in the presence
of a two fold excess molar ratio of Migfilin LIM 1 were superimposed and analyzed for
any apparent peak perturbations. The spectra shown in figure 5.4 clearly show that there
are no peak perturbation implying that the interaction between Kindlin 2 11-143 fragment
and Migfilin LIM 1 domain is insignificant. This experiment narrows down the binding
domains of Migfilin to LIM23 and residues 11-143 on Kindlin 2.
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In vivo assays have shown a strong interaction between Kindlin 2 1-218 (data not
shown) and Migfilin LIM domains. To evaluate whether the binding site is further
expanded beyond residue 143 in Kindlin 2, we needed an expression construct
encompassing residues 143-218.

Figure 5.4. 1H-15N HSQC superimposed spectra showing the interaction
between Kindlin 2 11-143 and Migfilin LIM 1 at 1:2 molar ratio. The
black spectrum corresponds to 1H-15N HSQC of Kindlin 2 11-143 and red
spectrum is the HSQC acquired of Kindlin 2 11-143 in the presence of
Migfilin LIM 1 domain.
An expression construct for Kindlin 2 95-268, engineered using pGST-1 vector, a
pGEX-4T-1 derived vector, had a very poor expression of the protein. Residues 95-268
of Kindlin 2 consist of partial F1 sub-domains and parts of F2. Optimization on
temperature of induction, time of induction etc, did not improve the expression. I made
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two smaller constructs by subdividing residues 95-268 into 95-168 and 168-268. I chose
these boundaries according to the Kindlin 2 model structure. Kindlin 2 95-168 protein
was a complete aggregate in size exclusion chromatography (with and without the fusion
tag). We were able to isolate Kindlin 2 168-268 as a GST fusion protein at its dimeric
state. To investigate the interaction between Migfilin and Kindlin 2, I performed a 2D
HSQC experiment. The spectra of Migfilin LIM23 were recorded in the absence and
presence of Kindlin 2 168-286-GST fusion protein. The data are shown in Figures 5.5.

Figure 5.5.

1

H-15N HSQC superimposed spectra of the interaction

between 15N Migfilin LIM23 and Kindlin 2 168-268-GST

As a control experiment, I recorded a HSQC experiment with GST protein as the
interacting partner, at a 1:2 molar ratio in the presence of
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15

N Migfilin LIM23. A

prominent chemical shift pattern is seen in the control spectra representing the influence
of the GST tag on Migfilin LIM23 domain.
After cleavage of the GST tag from Kindlin 2 168-268-GST fusion protein, a
majority of the cleaved protein tend to aggregate, while a much smaller fraction co-eluted
with the dimerized GST tag when subjected to size exclusion chromatography. Although
low in yield, Kindlin 2 168-268 protein is a tetramer.

Figure 5.6. 1H-15N HSQC superimposed spectra of
LIM23 in black and

15

15

N Migfilin

N Migfilin LIM23 in the presence of Kindlin 2

168-268 in red.

The superimposed HSQC spectra between 15N Migfilin LIM23 and Kindlin 2 168268 in the presence of 15N Migfilin LIM23 are shown in Figure 5.6. No significant peak
perturbations are observed in figure 5.6 which again implies that there is no significant
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interaction between Kindlin 2 168-268 and Migfilin LIM23 domains. The positive effect
seen earlier in figure 4.5 was due to the GST fusion tag.
Since, in vivo assays have shown an interaction between Kindlin 2 N-ter and
Migfilin LIM domains, we predicted that the remaining untested fragments of Kindlin 2
N-ter are responsible for the interaction. Unfortunately, Kindlin 2 95-168 fragment,
which is a region untested for the interaction, is completely aggregating. A closer look at
the amino acid sequence of Kindlin 2 95-168 revealed that there is a stretch of positively
charged lysines followed by alternating negatively charged amino acids. We rationalized
that this region may be the leading cause for aggregation. I made two shorter constructs
of Kindlin 2, residues 95-154 consists of the positively charged amino acid stretch
whereas residues 155-268 contains the negatively charged amino acids. Surprisingly, the
expressed protein of Kindlin 2 95-154 aggregates completely, being unavailable for
further analysis. Kindlin 2 155-268 behaves the same way as Kindlin 2 168-268 and is a
tetramer in size exclusion chromatography. A HSQC experiment with

15

N Migfilin

LIM23 and Kindlin 2 155-268 revealed no interaction.
The only stretch of amino acids of Kindlin 2 N-terminal region that have not been
tested for interaction with Migfilin LIM domains are residues 143-154. Having strong in
vivo data from our collaborators for positive and strong interaction between Kindlin Nterminal and Migfilin, we reasoned that residues 143 to 154 may impose binding. To test
our hypothesis we synthesized a peptide of residues 143-154 which comprise of amino
acids: KKPRDPTKKKKKKK. To investigate the nature of interaction between Migfilin
LIM23 domain and the synthesized peptide, we performed a HSQC experiment, which is
capable in detecting very weak interactions. Multiple HSQC spectra of
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15

N Migfilin

LIM23 domain protein with increasing molar ratios of the peptide were recorded. The
results shown in Figure 5.6 revealed no significant peak perturbations even at 1:4 molar
ratios.To summarize, we tested residue 1-268 of Kindlin 2 for the interaction with
Migfilin Lim domains. Among all the experiments, we have seen a weak interaction
between Kindlin 2 11-143 and Migfilin LIM23 domains.

Figure 5.7. Migfilin LIM23 with Kindlin 2 143-154 peptide. This is an
overlay of HSQC spectra between

15

N Migfilin Lim23 domain and that in

the presence of Kindlin 2 143-154 synthetic peptide.

The HSQC spectra of Kindlin 2 1-105 and 11-143 are not identical, but there are
certain peaks that are partially overlapping. In order to get a vague idea of the distribution
of the perturbed peaks by correlating them to the Kindlin 2 105 structure, we have seen
that most of the perturbed peaks are common to both constructs. This leaves us with the
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question whether the C-terminal residues 105-143 on Kindlin 2 has an effect on the
functional structure. Tracing back some of the perturbed residues on Kindlin 2 11143spectrum to the solution structure of Kindlin 2 1-105 reveals that peak clusters have
been perturbed. These are residues 23-25 and 83-85. A closer observation of the two
sequences in the Kindlin 2 model structure shows that the C-terminal residues of 95-143
are structured. As shown in figure 5.8, the F0 domain is highlighted in blue and parts of
F1 sub-domain in yellow. Figure5.8.(a) is the model structure Kindlin 2 1-105. Residues
95-105 in (a) denote a C-terminal single beta strand whereas in (b), Kindlin 2 11-43
construct, the C-terminal 95-143 sequences are structured in to an anti-parallel beta sheet

(a)

(b)

Figure 5.8. (a) Kindlin 2 1-105 model structure and (b) Kindlin 2 11-143
model structures in ribbon diagrams, obtained from Kindlin 2 model 1
structure. The residues in blue correspond to 1-95 F0 domain and the
residues in yellow correspond to 96-105 in (a) and 95-143 in (b).

and a short helix. According to the solved 3D structure of Kindlin 2 1-105 (Chapter III),
residues 100-105 are unstructured. There is a possibility that the C-terminal residues
highlighted in yellow in (b) may influence a functional conformation on F0 domain. If so,
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this might be a reason for the positive interaction between Kindlin 2 11-143 / Migfilin
Lim23 domains and negative interaction between Kindlin 2 1-105 / Migfilin LIM23
domains. It is quite evident that Kindlin 2 N-ter has a positive influence for Migfilin LIM
domain interaction. In vivo studies used a larger fragments for analysis. But due to size
limitation in NMR, fragmentation was a necessity. We cloned larger fragments of Kindlin
2, but unfortunately, Kindlin 2 1-218 had no expression.
To summarize, all data above suggest that there is a very weak interaction
between Kindlin 2 full length/N-terminal and Migfilin LIM domains. According to our
schematic representation of integrin activation, the link between Migfilin and Kindlin
play a crucial role in the establishment of the link between the actin cytoskeleton and the
extracellular matrix. Continuing evidence from in vivo studies from our collaborators has
strong support for the interaction between Kindlin 2 N-ter and Migfilin. However, or
NMR studies did not record a significant binding interaction further analysis are required
to pin-point the binding interfaces.

5.2. The role of Kindlin 2 and Migfilin in integrin activation.
5.2.1.Introduction
Migfilin and Kindlin are key molecules in the process of integrin activation. Talin
H domain of Talin is a well known activator of integrins and the mechanism of Talin H in
integrin activation has been widely accepted (Calderwood, 2004; Garcia-Alvarez et al.,
2003; Vinogradova et al., 2002) The importance of Kindlin in integrin activation has
been recently implicated (Ma et al., 2008). Migfilin is known to bind to Filamin and
Kindlin. The importance of the interaction between Migfilin and Filamin is well
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established. The interaction between Migfilin and Kindlin is important to recruit Migfilin
to the focal adhesion site (Tu et al., 2003). Besides, it is interesting to know how the
interaction between Migfilin and Kindlin may affect in the process of integrin activation.
To understand the role of Migfilin/Kindlin in the complex process of integrin
activation, in collaboration, we performed a series of NMR, ITC, SPR and in vivo
functional experiments, which will be analyzed and discussed throughout the next subchapter.

5.2.2. In vivo functional evidence for the role of Migfilin in Talin and Kindlin 2 induced
integrin activation.
A very recent in vivo study performed by Dr. Ma Yang-Qing in Dr. Ed. Plow Lab
revealed a few important facts on the role of Migfilin in Talin and Kindlin 2 induced
integrin activation. The results of the integrin activation assays are summarized in
Figures 5.9 and 5.10 below. Each experiment shows the median of 3 experiments of
PAC1 binding. PAC1 is a ligand for the binding of activated αIIbβ3 integrins. Figure 5.8
shows that there is an enhanced activation of integrin in the presence of Migfilin-Talin
H–Kindlin2 compared to Talin H-Kindlin 2 or Talin H alone. This clearly shows the
positive role of full length Migfilin in Talin H and Kindlin2 induced integrin activation.
Figure 5.8 further shows that integrin αIIbβ3 activation is diminished in the
presence of over-expression of only Migfilin-Kindlin2 (last lane). This further supports
the well-established role of Talin H in integrin activation and confirms that Talin H is the
key molecule to propagate integrin activation.

91

The functional role of Kindlin2 in Talin induced integrin activation was
heightened in Figure 5.9.-lane 5. Over-expression of Migfilin and Talin H show the same
level in PAC1 binding to activated integrins compared to Talin H. This implies that
Migfilin has no effect on enhancing the effect of integrin activation without Kindlin 2. In
other words, the interaction between Kindlin and Migfilin may play a significant role in
integrin activation.
To summarize the data in figure 5.9: TalinH is sufficient for the activation of
integrins. Kindlin and Migfilin have a cofactor effect for the role in Talin induced
integrin activation. The interaction between Kindlin and Migfilin is necessary to show the
effect of Migfilin in integrin activation.

Figure 5.9. Integrin activation assay. Effect of Migfilin on Talin and
Kindlin 2 induced integrin activation. CHO cells are stably expressing
αIIbβ3, transfected with cDNAs of each Talin head domain, Talin headKindlin 2, Talin head – Kindlin 2-Migfilin, TalinH-Migfilin and Kindlin2 and
Migfilin (Ma et al., 2008).
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Migfilin is an adaptor protein comprising of 373 amino acids. Structurally, the Cterminal LIM domains have shown to mediate the interaction with Kindlin (Tu et el,
2003). The unstructured N-terminal region interacts with Filamin and act as a negative
regulator in integrin activation (Ithychanda et al., 2009b; Ithychanda et al., 2009c). The
central proline rich region has two binding sites for Src and VASP. Migfilin is the
initiator of the Src pathway and prevents and protect against apoptosis (Zhao et al.,
2009). To investigate the effect of each domain of Migfilin in the role of Migfilin in
integrin activation, another integrin activation assay was performed by Dr. Ma, YangQing, incorporating Migfilin sub-domain proteins (Figure 5.10.).
Migfilin(s) is an isoform of Migfilin, which lacks the proline rich region. To evaluate the
functional role of the proline rich region in integrin activation Migfilin(s) isoform was
overexpressed and the extent of αIIbβ3 binding was monitored. Similarly, the effect of
Migfilin 1-85 and the C-terminal LIM domains were monitored and the data are shown in
Figure 5.10. According to the figure, a significant decrease in PAC1 binding could not be
observed for Migfilin(s), demonstrating that the proline rich region of Migfilin has no
contributory effect in integrin activation.
Figure 5.10 shows deletion of N and/or C terminal domains, reduce PAC1 binding
heightening the importance of both regions as a cooperate role in integrin inside-out
signaling mechanism.
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Figure 5.10. Integrin activation assay. Effect of Migfilin subdomains on
Talin and Kindlin 2 induced integrin activation. CHO cells are transfected
with cDNAs of each Talin head domain, Talin head- Kindlin 2, Talin head –
Kindlin 2-Migfilin(s), TalinH-Migfilin and Kindlin2 and Migfilin Nterminal
1-85residues, TalinH-Migfilin and Kindlin2 and Migfilin C-terminal LIM
domains (Ma et al., 2008)

Migfilin N-terminal 1-85 residues are well known to bind to Filamin, thereby
removing Filamin from integrin CT and makes integrin available for potent activation by
Talin and Kindlin 2 (Ithychanda et al., 2009a; Ithychanda et al., 2009b) (Lad et al., 2008;
lad et al., 2007). Over expressing Migfilin N-terminal 1-85 in CHO cells would remove
Filamin from integrin tails allowing the CT available for potential activation by Talin and
Kindlin. Being the only negative regulator identified to remove Filamin from integrin CT
tail; Migfilin N-terminal region plays a very important role to initiate the process of
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integrin activation. Interestingly, the LIM domains of Migfilin show an equal importance
in integrin activation. The only known link of Migfilin LIM domains is its interaction
mediated by Kindlin 2. Kindlin 2 protein recruits Migfilin to the focal adhesion site,
allowing it to regulate the inhibitory effect of Filamin (Tu et el, 2003).
To summarize, this assay demonstrates the functional importance of both C and N
terminal of Migfilin for integrin activation and deleting either of it would substantially
diminish integrin activation.
Despite the role in recruiting Migfilin to FA, Kindlin also interacts with integrin
to heighten the effect of integrin activation. In focal adhesions, Talin H, Kindlin 2 and
Migfilin are spatially close. NMR data have shown that there is no interaction between
Kindlin F0 and Talin H domain. We questioned, whether there is a secondary interaction
between Migfilin and Talin H. We hypothesized, whether Migfilin bridges Talin H and
Kindlin N-ter and thereby forming a ternary complex, which may stabilize the interaction
with integrin. The next subchapter evaluates our hypothesis through a series of NMR and
SPR experiments.
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5.2.3. The relationship between Migfilin and Talin interaction
To test our hypothesis introduced in the previous subchapter, we performed a
series of HSQC, in vivo and SPR experiments. These help us to understand the
interaction between Talin H and Migfilin subdomains.
The first step was to obtain Talin H and subdomain proteins to perform
interaction experiments. I subcloned Talin H domain and its subdomains into pHis-1
vector as explained in chapter II -methods and materials section. After expression and
purification of the proteins, I performed a 2D-HSQC experiments between

15

N labeled

Talin His fusion proteins and unlabeled Migfilin LIM and vice versa. Data summarized in
figure 5.11 show a site specific interaction between Migfilin LIM domains and all

15

N

labeled his tag-Talin subdomains: TalinH, TalinF0F1, TalinF0 and TalinF1. The
chemical shifts were dose dependant. The reverse experiments of

15

N labeled Migfilin

LIM domains and unlabeled Talin subdomains were positive. To further confirm this
interaction, I performed an SPR analysis. The results revealed a very weak interaction
between Talin F0F1 and Migfilin LIM domains with a 40µM and 3µM affinity for Talin
F0F1 and F0 domains respectively.
I performed another group of experiments without the His tag of Talin subdomain
proteins and Migfilin LIM domains. Interestingly, the interaction was completely
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(a)

(b)

(c)
Figure 5.11. 1H-15N HSQC of 15N Migfilin LIM domains and Talin subdomains.
Figure (a) shows the interaction between 15N Migfilin LIM 23 domain and unlabeled
Talin head domain. Spectrum (b) shows the interaction between Migfilin LIM 23
domain and Talin F0F1 subdomains. Figure (c) shows the interaction between
Migfilin LIM23 domains and Talin F0 domain. All spectra show significant chemical
shift perturbation.
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(a)
Figure 5.12. 1H-15N HSQC of

(b)
15

N Talin subdomains and Migfilin LIM

domains. Figure (a) shows the interaction between

15

N Talin F0F1 and

Migfilin LIM 23 domain. Spectrum (b) shows the interaction between Talin
F0 and Migfilin LIM 23 domain. All spectra show significant chemical shift
perturbation.

abolished (Figure 5.13). These experiments heighten the effect of the His tag on LIM
domain proteins. However, further analyses are necessary to validate our results.
Although we have eliminated the possibility between the interaction of Talin H
domain and Migfilin LIM domains, we questioned whether the rest of Migfilin, the
proline rich region and/or the N-ter 1-85 residues may have an effect on Talin H binding.
Migfilin 1-85 and 1-36 were kindly provided by Dr. Sujay Itchichanda. We performed
2D HSQC experiments to evaluate our hypothesis.
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(a)

(b)

Figure 5.13. 1H-15N HSQC of 15N Talin subdomains without the HIS tag
and Migfilin LIM domains. Figure (a) shows the interaction between 15N
Talin F0F1(after cleavage of HIS tag) and Migfilin LIM 23 domain.
Spectrum (b) shows the interaction between Talin F0 (after cleavage of HIS
tag) and Migfilin LIM 23 domain. All spectra show no significant chemical
shift perturbation.

We analyzed the interactions of 15N Migfilin 1-86 - Talin F0F1/F1 and 15 N Talin
F0/F0F1 – Migfilin 1-36mer by NMR-HSQC. We were not able to observe any
significant chemical shift perturbations evidencing no interaction between Talin and
Migfilin N-ter. An in vivo experiment performed by our collaborators showed a negative
interaction between Migfilin proline rich region and Talin H.
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5.3. Summary of chapter 5 results.
NMR, SPR, ITC and in vivo assays have been used through out this thesis work,
to understand the molecular role of Kindlin 2 in the process of integrin activation. Among
the binding partners of Kindlin 2, the link between Kindlin 2 and Migfilin plays an
indispensible role in integrin activation. To understand and validate the interaction
between Kindlin 2 N-ter and Migfilin (obtained from in vivo assays), NMR was used as
our primary method of analysis.
To summarize, a very weak interaction was observed between Kindlin 2 full
length/N-terminal 11-143 and Migfilin LIM domains. Continuing evidence from in vivo
studies from our collaborators has strong support for the interaction between Kindlin 2 Nter and Migfilin. According to our schematic representation of integrin activation, the link
between Migfilin and Kindlin play a crucial role in the establishment of the link between
the actin cytoskeleton and the extracellular matrix.
Integrin activation assays demonstrated the functional importance of both C and
N terminal of Migfilin for integrin activation and deleting either of it would substantially
diminish integrin activation. Our experiments have not recorded any interaction between
Talin H domain and Migfilin full length protein. This eliminates our hypothesis on the
formation of a ternary complex between Migfilin-Talin H-Kindlin 2 N-ter, which may
help to stabilize activated integrin and enhance the effect of integrin activation.
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CHAPTER VI

KINDLIN C-TER AND INTEGRIN INTERACTION

6.1. Introduction.
Kindlin 2 C-term plays a significant role in integrin activation (Shi et al., 2007;
Ma et al., 2008). A number of health related issues have been linked to the failure of Cterm Kindlin to interact with integrin CT. Thus, to investigating its role in integrin
activation is becoming an area of interest. Up to date, there is no structural information
available to evaluate the role of Kindlin proteins in integrin activation. Kindlin 2 F3
subdomain and Talin F3 subdomain have similar homology. Through homology
modeling, Ma et al. have mapped the interaction between Kindlin F3 and integrin CT
(Shi et al., 2007; Ma et al., 2008; Bledzka et al., 2010). A structure based analysis of the
interaction between Kindlin and integrin CT, would be necessary to understand and
evaluate its mechanism in integrin activation. Up to date, there is no information
available for the C-ter or full length structure of Kindlin. Lack of structural information
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of Kindlin makes it difficult to evaluate the molecular role of Kindlin 2 C-ter in integrin
activation.
In order to evaluate and perceive an atomic level understanding of the interaction
between Kindlin C-ter and integrin, we undertook an extensive analysis of Kindlin 2 Cterm. The next subchapter evaluates the attempt taken to obtain Kindlin 2 C-ter protein/s.

6.2. Expression of Kindlin 2 C-terminal.
To investigate the role of Kindlin 2 C-ter, obtaining the 3D structure of the
protein is a necessity. As described in chapter 2, to initiate the process of recombinant
protein expression, a prediction of the secondary structure of Kindlin 2 C-ter is helpful. In
the process of cloning subdomain structures of Kindlin 2, the predicted secondary
structural information would be beneficial in choosing the correct boundaries for the
prospective protein (Appendix 1- Secondary structure prediction of Kindlin 2).
The boundaries that have been chosen were selected within the coiled region of
high probability without disturbing the predicted secondary structure. Several boundaries
been chosen are: residues 565-658, 565-680, 485-680 and 567-662. Their fusion tag,
bacterial strain, solubility etc are summarized in Table 4.2.
All the constructs of the C-terminal F3 subdomain, have either no expression or a
very low expression. The expressed protein is completely in the insoluble fraction of the
cell. We reasoned that poor expression of F3 could be due to the presence of multiple rare
codons in the sequence. To evaluate this we expressed the protein in Rosetta 2 and RIP
bacterial host strains, which are supplemented with additional plasmids for the expression
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of rare tRNA codons in E.coli. A significant increase in the level of expression could not
be seen even in Rosetta 2 bacterial host strain.
The next approach was to obtain F2 subdomain of Kindlin 2. Although the Cterminal F2 constructs have a higher level of expression, the expressed protein tends to be

MIG-2
BOUNDARIES

FUSION
TAG

565-658

567-662
567-665
567-680
394-567

BACTERIAL
HOST STRAIN

PROTEIN
EXPRESSION

PROTEIN
SOLUBILTY

GEL
FILTRATION

GST
BL21 (DE3)
MBP-HIS BL21 (DE3)
BL21 (DE3)pLys
Rosetta (DE3)
Rosetta 2 (DE3)

no expression
no expression
no expression
no expression
low expression

in pellet

HIS
GST
HIS

Rosetta 2
Rosetta 2
Rosetta 2

low expression
low expression
low expression

in pellet
in pellet
soluble

Aggregate

GST

Rosetta 2

low expression

soluble

Aggregate

Table 6.1. Summary of Kindlin 2 C-terminal constructs, their
expression vectors, expression conditions and gel filtration data.

a complete aggregate when subjected to size exclusion chromatography. We reasoned,
with evidence with the model structure, that F2 subdomain is packed against the potential
PH domain and isolating F2 subdomain itself may expose hydrophobic residues/patches
that might have initiated aggregation of F2. However, a construct including PH-F2
domains did not substantially reduce the aggregation evidencing that the PH domain
alone may not help the problem. To understand whether aggregation is due to improper
folding of the protein we assisted protein folding by introducing chaperones during
protein expression. However, we were not able to observe any sort of an oligomeric state
other than an aggregate when subjected to gel filtration. A close analysis of the sequence
revealed multiple cysteine residues. We rationalized that intermolecular disulfide bond
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formation may promote protein aggregation at an early stage of the protein purification
process. A site directed mutation of C471A and C520S of Kindlin 2 459-567 construct of
F2 subdomain did not prevent aggregation at all. To further reason out the effect of buffer
interferences we performed the purification process in multiple buffers. PBS buffer at pH
7.0 was used for most protein purification protocols. We change the buffer to MES at pH
6.4 and Tris-HCl at pH 8.0. Results showed that change in buffer did not help in
preventing or reducing the fact that the protein is aggregating. As an additional step we
reasoned that protein stabilizing agents like cryotropes, kosmotropes, detergents etc may
help to prevent aggregation when added throughout the protein purification process. I
performed an aggregation assay (Saunders et el., 2008) using a wide variety of buffer
additives. None of the additives helped except 1% sarkosyl. Sarkosyl is a very strong
detergent, which is known to rupture the tertiary structure of the protein. Since sarkosyl
helped partially to prevent/reduce aggregation we think that aggregation is initiated
through hydrophobic contacts. We are limited by choosing additives because of NMR
compatibility. None of the approaches helped so far to shift the Kindlin 2 F2 domain
protein from being an aggregate to a lower order oligomer or monomer.
To summarize, we have cloned Kindlin 2 C-ter extensively. However we were not
able to obtain any subdomain protein due to various difficulties in expression and
aggregation of the protein.
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6.3.Summary of chapter 6 results
The attempts of obtaining the C-terminal subdomain protein of Kindlin 2 failed
due to varying degrees of difficulties in expression constructs. Certain approaches are
outlined in chapter v, which could be useful in future to guide through to obtain Kindlin 2
C-ter protein for prospective functional analyses.
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CHAPTER VII

DISCUSSION AND FUTURE DIRECTIONS

This thesis work has been concerned with understanding the role of Kindlin 2 in
integrin activation. Our primary focus is to understand the function of Kindlin 2 in a
structural point of view, which will give us more insight to understand the mechanism of
Kindlin 2 at atomic level. Initial trials of full length Kindlin 2 protein expression were
low and we were not able to obtain sufficient amounts for structural analyses. However,
we were able to obtain subdomain proteins of Kindlin 2 after extensive subcloning.
Currently, we have Kindlin 2 F0 domain (residues 1-105 and 11-143), Kindlin 2 F1
fragment (residues 155-268 and 143-154 peptide) and Kindlin 2 PH domain. The F0
domain is a high yielding and stable protein suitable for NMR studies. We have obtained
the structure of Kindlin 2 F0 domain through solution NMR. Kindlin 2 155-268 is a
tetramer and NMR structure determination would not be feasible. However, X-ray
crystallography could be the method of choice for Kindlin 2 155-268 structure.
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Kindlin 1 and 2 F0 domains have a similar beta grasp fold. The structures show minor but
distinct differences that lead us consider with the possibilities of functional differences
between Kindlin 1 and 2 F0 domains. Thus evolutionary, the structural differences in the
F0 domains may have developed for potential functional differences. There are no facts
in literature that show functional differences between the F0 domains. As a future step it
would be interested to investigate whether these minor differences in structure may
impose significant differences in their function.

A remarkable finding during this thesis work is that Kindlin 2 F0 domain plays a
fundamental role in integrin activation. Deletion of F0 domain from full length Kindlin 2
substantially reduced integrin activation (due to PAC1 binding) in comparison to full
length Kindlin 2. One goal of this thesis was to understand how Kindlin 2 F0 contributes
in the integrin activation mechanism i.e. to find the structural determinants of Kindlin F0
domain and understand its central role in integrin activation. We have observed a weak
interaction of the F0 domain with the membrane, PIP3 and integrin β3 CT membrane
proximal residues and a 1µM affinity of PH and PIP3. All these data show that F0 and
PH domains of Kindlin 2 interact with the membrane surface. Based on our and our
collaborators data we proposed that Kindlin F0 and PH domain tether to the membrane to
enhance the effect of Kindlin 2 in integrin activation (Figure 7.1.).

107

Figure 7.1. Schematic diagram of the proposed model of integrin
activation. This shows that integrin CT is associated with Filamin through
multiple binding sites and maintains integrin at the resting state or inactive
state. Upon activation, Talin binds to the membrane proximal β3 CT,
Kindlin is tethered to the membrane via the PH domain and facilitates the
interaction between Kindlin C-ter F3 and integrin CT.

A closer look at the N-terminal sequence of Kindlin 2 shows a stretch of multiple
positive charges encompassing the nuclear localization signal between the PH domain
and F0 domain. There is a possibility, that these positive charges on Kindlin 2 may help
the full length protein to anchor to the negatively charged membrane surface. This may
further strengthen our hypothesis, where multiple domains of Kindlin 2 or in part may
interact with the membrane surface essentially to tether Kindlin 2 to the membrane to
facilitate the effect of Kindlin 2 in integrin activation. A future direction to validate our
hypothesis is a thorough analysis using structure based mutagenesis and functional
assays. Papayannopoulos et al. have shown that a polybasic motif in N-WASP directly
binds to PIP2 and regulates its activity (Papayannopoulos et al., 2003). There is a
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possibility that the polybasic motif of Kindlin 2 may also has some regulatory
significance. It would be interesting to analyze whether this poly basic stretch of residues
in Kindlin 2 play a role in membrane anchoring or has a regulatory function.
According to our data and literature, both F0 domain and F3 domain of Kindlin 2
and Talin F3 domain interact with the integrin β3 CT. It is quite interesting how all these
proteins may bind to the ~50 amino acid length β3 cytoplasmic tail of integrin. Observing
the model structures of Kindlin 2, it is clear that Kindlin 2 N-ter F0 and C-ter F3 domains
are spatially close. In a 3D space, it is possible that all above mentioned domains have
contact with the β3 CT.
The binding sites on Kindlin 2 F0 domain structure, due to integrin interaction in
blue and membrane interaction in magenta is shown below. It is clear from figure 7.2.
that the interaction sites are not overlapping. This supports our hypothesis that Kindlin F0
domain interacts with the membrane and partly facilitates the effect of Kindlin 2 in
integrin activation.

(a)

(b)

(c)

Figure 7.2. Kindlin 2 F0 dmain structure. Highlighted residues are due
to integrin interaction (partly) in blue and PIP/membrane interaction in
magenta. (a) Ribbon diagram (b) surface view (c) surface view after 180
deg rotation from (b).

109

Another aspect in this multi-collaborative-project is to understand the significance
of Migfilin and Kindlin 2 interaction. Among the binding partners of Kindlin 2, the
interaction between Kindlin N-ter and Migfilin plays an indispensible role in recruiting
Migfilin to focal adhesion (Tu et al., 2003). To validate the interaction obtained from in
vivo assays and understand the interaction specifics between Kindlin 2 N-ter and
Migfilin, NMR was used as our primary method of analysis.
Our results show an interaction between Kindlin 2 11-143 residues with Migfilin
LIM23 domains. However, further truncation of the protein abolished the interaction
between Kindlin and Migfilin. We postulate that the F1 subdomain (F1 fragment), which
is C terminally located from the F0 domain, may impose an effect on the core F0 domain
structure and facilitates the interaction with Migfilin LIM domains. Evidence from our
collaborators has reported a positive interaction between the Kindlin 2 N-ter 1-218 and
Migfilin LIM domains. The facts that:
1. We only observed an interaction between Kindlin 2 11-143 and Migfilin LIM
domains although we screened all fragments of Kindlin 2 1-268 protein in vitro.
2. Truncation of Kindlin 2 11-143 abolished the interaction with Lim domains in
vitro.
3. A larger fragment of 1-218 show a positive interaction in vivo
supports our hypothesis of a 3D functional structure, which is distorted during truncation
of larger a fragment into smaller sub-domain proteins of Kindlin 2.
All model structures of Kindlin 2 show that the F0 and F1 fragments (highlighted in
yellow and red) residues 1-276 form a well defined core structure (see below). The core
(shown by an arrowhead) is surrounded by localized positive and negative charges. It is
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possible that this structure is the functional structure that mediates Migfilin LIM domain
interaction. Truncation may distort the functional structure and abolish interaction, which
is consistent with our data.

+

Figure 7.3. Part of the full length Kindlin 2 Model 1 highlighting F0
domain in blue and F1 fragments in yellow and red.
An expression construct made for Kindlin 2 1-276 had no significant protein
expression. We were able to obtain F0 (blue) and 155-268 residues (red and part of
yellow) separately. Expression constructs with incorporation of the positive charges,
Kindlin 2 1-154, 1-177, 11-158, are either insoluble or are soluble aggregates. If the
interaction between Migfilin and Kindlin 2 is mediated via the F0-F1 core structure,
obtaining the protein would be a necessary step.
Model structures of Kindlin 2 display that the F0 subdomain of Kindlin 2 holds a
central position in the structure. It forms a core structure together with F1 subdomain
fragments on one side and is in close contact with other domains in the structure. This
positioning of F0 domain may stabilize all interacting domains of the structure. There is a
possibility that deleting F0 domain from the full length protein may perturb the 3D
structure. This may influence the interaction/association with integrin and other proteins
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like Migfilin. The integrin activation assay shown in figure 4.1. in chapter 4 shows that
deletion of the F0 domain from the full length Kindlin 2 abolish integrin activation,
demonstrating the central role of Kindlin 2 F0 domain. In order to understand the position
of the F0 domain in the full length protein, the 3D structure of Kindlin 2 is necessary.

Kindlin 2 is a phosphor protein where residues 159 and 181 are phosphorylated.
In vivo assays have demonstrated a positive interaction for Kindlin 2 1-218. The two
potential phosphorylation sites are located within 1-218 residues. Kindlin 2 for in vivo
analysis was purified from mammalian cells and for in vitro analysis from bacterial
expression systems. Bacteria lack the bio mechanism for many types of post-translational
modifications. If a post-translational modification such as a phosphorylation is necessary
for the interaction between Kindlin 2 and Migfilin, in vitro experiments would not detect
the interaction. There are many examples in literature to support this kind of
phenomenon. One example is the interaction between the integrin cytoplasmic tail and
Dok1 protein. Dok1 is cytoplasmic protein and is involved in many signaling pathways.
It also plays an important role in cell migration (Yamanashi et el, Cell 1997; Noguchi et
el, EMBO J 1999). Both Talin PTB and Dok1 PTB domains binds to the central NPxY747
motif of the β3 integrin CT. The major difference of this interaction is that Dok1
negatively regulate integrin activation and Talin activates integrin (Wegener, K.L. et el,
cell 2007). This contrasting role of function occurs due to one simple modification in the
sequence. Phosphorylation of Tyr747 residue shows a dramatic change in binding
affinities. Another more recent example explains that Kindlin 2 PTB domain itself shows
a higher affinity for non-phosporylated Y759 on integrin CT than the phophorylated tail
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(Bledzka et al., 2010). There are many types of post-translational modifications that can
occur in mammalian cells and not found in bacterial cell machineries. Phosphorylation is
one such mechanism that change or control the behavior of the protein. Kindlin and
Migfilin are relatively large proteins with multiple phosphorylation sites. So the only way
to incorporate potential PTM is to grow the protein in a mammalian expression system,
insect cell expression systems or the more common baculovirus insect cell expression
system.
Although an interaction between Kindlin 2 N-term and Migfilin LIM domains
was observed in biological assays, we were not able to pin down the exact binding
interface/s using in-vitro studies (NMR, SPR and ITC experiments). As described above,
the possibilities of (1) a distortion in the function 3D structure through subcloning, (2) a
post-translational modification at the binding surface in Kindlin or Migfilin (3) a central
role of F0 domain in the full length protein could be reasoned, and investigating and
evaluating these possibilities would be a future necessary step for the molecular level
understanding of the role of Kindlin and Migfilin in integrin activation.
The interaction between Kindlin 2 and Migfilin plays a significant role in cell
adhesion processes. In addition to the structural role in the cell by forming a connection
via the ECM and actin cytoskeleton, Kindlin-2 and Migfilin have become essential
elements in the process of integrin activation. Our data on integrin activation assays in
figures Fig 5.9 and 5.10 have emphasized the significance of both Kindlin and Migfilin in
Talin induced integrin activation. How does Migfilin contribute to enhance integrin
activation? Our hypothesis of the formation of a ternary complex via Migfilin-Kindlin Nter-Talin H interactions would stabilize the interaction with integrin CT thereby

113

heightening the effect of activated integrins was evaluated giving particular interest to
Migfilin and Talin H interaction. Our data have eliminated the possibility of this
interaction using NMR. How does Migfilin overexpression enhance the effect of integrin
activation? From literature it is evident that Migfilin N-ter removes the negative
regulatory effect of Filamin from the integrin CT. Kindlin 2 and Migfilin interaction
recruits Migfilin to the focal adhesion site allowing Migfilin N-ter to interact with
Filamin. Further analyses are necessary to evaluate and understand the cooperate role of
Migfilin/Kindlin/TalinH in integrin activation.

The role of Kindlin C-term F3 domain in Talin induced integrin activation has
been demonstrated in literature. However, up-to-date there are no structural studies on
Kindlin 2 C term been reported. As a goal of this thesis work, we have been extensively
subcloning and optimizing the C-term Kindlin 2 in order to obtain a soluble protein for
structure based analysis. Despite the varying number of bacterial expression systems,
vectors, fusion tags, mutations, optimization strategies, we were not able to obtain a
soluble monomeric protein for the C-term of Kindlin 2. For the molecular level
understanding of integrin activation, the structure of Kindlin is a necessary component. In
future work, it is beneficial to further subclone changing the boundaries of the protein in
the scope of obtaining a suitable protein. As an immediate future step, subcloning from
lower species like mouse and C. elegans would be helpful. The mouse and human
Kindlin 2 amino acid sequences have a 98% similarity while the DNA sequences show
87% homology. Obtaining the Kindlin 2 C-term protein will allow us to evaluate the
interaction between Kindlin C-term and integrin and investigate the prospective auto

114

inhibitory mechanism. Certain approaches outlined here, could be useful in future to
guide to obtain Kindlin 2 C-ter protein for prospective functional analyses.
Modeling studies suggest that there is a possible interaction between the N-ter and
FERM domain of Kindlin 2. A similar interaction is seen in Talin. (Goksoy et al., 2008).
Talin rod domain and PTB domain interaction keeps Talin in its inactive dimeric
conformation. PIP2 disrupts the binding interface between the rod domain and PTB
domain and opens up the binding interface for integrin activation. Having similar
structural architecture and binding patterns, we assume that similar to Talin, Kindlin
obtains an inactive conformation through N-ter and C-ter interaction. In vivo data from
on-going studies have clearly shown that Kindlin 2 interacts with PIP3. Based on this
data we further hypothesize that the active conformation is revealed through potent PIP3
interaction.
In addition to Talin, N-WASP, an actin polymerization protein, is another protein
where the C-ter and N-term interaction is disrupted by potent PIP2 and Cdc42 binding.
PIP2 binds to a polybasic stretch in the sequence which perturbs the C and N terminal
interaction thereby revealing the active form of N-WASP (Venizelos Papayannopoulos et
el, 2007, Molecular cell). A similar sequence motif of positively charged residues is
found in Kindlin 2, residues 148-154. The fact hat modeling structures suggest that there
is a Kindlin C-ter and N-ter interaction and PIP3 disrupts the interaction may support our
hypothesis on the proposed autoinhibition mechanism for Kindlin 2. Obtaining the Cterminal protein will be first step to conduct a detailed analysis in order to support the
prospective auto-inhibitory mechanism of Kindlin 2.
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To conclude, Kindlins play an indispensable role in integrin activation. The role
of Kindlin 2 C-ter has been determined (Ma, Yang-Qing et al., 2008). However, up-todate there is a lack of information in literature about the role of the N-ter domains of
Kindlin 2. Here we have elucidated certain interacting partners of Kindlin 2 N-ter and
hypothesized its role in integrin activation. In brief, we have solved the structure of the
F0 domain of Kindlin 2 and have elucidated specific non-overlapping binding sites on F0
due to integrin β3 and PIP3 binding. In support with other in vivo and in vitro data, we
hypothesized that the Kindlin 2 N-terminal domain/s interacts with the membrane and
helps the full length Kindlin 2 protein to anchor to the membrane surface. This
interaction may stabilize Kindlin 2 and helps to facilitate the effect of Kindlin 2 in
integrin activation. In addition, we have elucidated that the F0 domain has partially
overlapping binding sites with the membrane and Migfilin LIM domains. Kindlin 2 F0
deletion constructs completely abolishes integrin activation, further heightening the
significance of Kindlin 2 F0 domain. Overall, this work has given a better understanding
of the of Kindlin 2 N-ter.
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APPENDIX 1
Kindlin 2 Full Length human PSIPRED PREDICTION RESULTS
Conf: Confidence (0=low, 9=high)
Pred: Predicted secondary structure (H=helix, E=strand, C=coil)
AA: Target sequence
# PSIPRED HFORMAT (PSIPRED V2.5 by David Jones)

Conf: 973631256777403402368996278854799998145147999999988768543221
Pred: CCCCCEECCCCCEECCEEEEEEEECCCCCEEEEEEEECCCHHHHHHHHHHHHCCCCCCCC
AA: MALDGIRMPDGCYADGTWELSVHVTDVNRDVTLRVTGEVHIGGVMLKLVEKLDVKKDWSD
10
20
30
40
50
60
Conf: 000218534033531112353012326330113357616998599977899974270079
Pred: CCCCHHHHCCHHHHHHHHHHHCCCCCCCCCCCCCCCCEEEEECCCCCEEEEEEECCCHHH
AA: HALWWEKKRTWLLKTHWTLDKYGIQADAKLQFTPQHKLLRLQLPNMKYVKVKVNFSDRVF
70
80
90
100
110
120
Conf: 999998888087871000123578551332102464323432101688745778877565
Pred: HHHHHHHHHCCCCCCHHHCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCC
AA: KAVSDICKTFNIRHPEELSLLKKPRDPTKKKKKKLDDQSEDEALELEGPLITPGSGSIYS
130
140
150
160
170
180
Conf: 888876767866666788746776545677532456776324589988855753146726
Pred: CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCH
AA: SPGLYSKTMTPTYDAHDGSPLSPTSAWFGDSALSEGNPGILAVSQPITSPEILAKMFKPQ
190
200
210
220
230
240
Conf: 688987323576787840120686999789999802245124888672553101245565
Pred: HHHHHHHCCCCCCCCCCCHHHCCCCCCCEEEEEEECEEEECCCCCCCCEEEEEHHHHHHH
AA: ALLDKAKINQGWLDSSRSLMEQDVKENEALLLRFKYYSFFDLNPKYDAIRINQLYEQAKW
250
260
270
280
290
300
Conf: 663488556899998860300112102456776777666610343787500121670178
Pred: HHHCCCCCCCHHHHHHHHHHEEEEECCCCCCCCCCCCCCCCHHHHHHHHHCCCEEEECCC
AA: AILLEEIECTEEEMMMFAALQYHINKLSIMTSENHLNNSDKEVDEVDAALSDLEITLEGG
310
320
330
340
350
360
Conf: 767520022000766320100152122334430368999706365430732327572334
Pred: CCCCCCHHHHCCHHHHCCCHHCCCCCCCCCCCEEEEEEEECCEEEEEECHHHCCCCCHHH
AA: KTSTILGDITSIPELADYIKVFKPKKLTLKGYKQYWCTFKDTSISCYKSKEESSGTPAHH
370
380
390
400
410
420
Conf: 156762451010004662017998304898426999448756688787750333165300
Pred: CCCCCCEEECCCCCCCCCEEEEEEECCCCCCEEEEEECCCHHHHHHHHHHHHHHHCCCCC
AA: MNLRGCEVTPDVNISGQKFNIKLLIPVAEGMNEIWLRCDNEKQYAHWMAACRLASKGKTM
430
440
450
460
470
480

129

Conf: 012205899999999971699987432731246677820034378828875002468999
Pred: CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHH
AA: ADSSYNLEVQNILSFLKMQHLNPDPQLIPEQITTDITPECLVSPRYLKKYKNKQITARIL
490
500
510
520
530
540
Conf: 975442288999999999999874500041189998508886339999331412126357
Pred: HHHHHHCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCCCEEEEECHHHEEEECCCC
AA: EAHQNVAQMSLIEAKMRFIQAWQSLPEFGITHFIARFQGGKKEELIGIAYNRLIRMDAST
550
560
570
580
590
600
Conf: 977899861200013258985499985167531789999478132477877779888256
Pred: CCEEEEEECCCCCCCCCCCCCEEEEEECCCCCCEEEEEEECCCHHHHHHHHHHHHHHHCC
AA: GDAIKTWRFSNMKQWNVNWEIKMVTVEFADEVRLSFICTEVDCKVVHEFIGGYIFLSTRA
610
620
630
640
650
660
Conf: 01057300888777415769
Pred: HHHCCCCHHHHHHHHCCCCC
AA: KDQNESLDEEMFYKLTSGWV
670
680
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APPENDIX 2.
Talin and PIP interaction studies.

Activation of integrin heterodynamic receptors is essential for ligand binding and
subsequent cellular signaling and cellular processes. Talin H domain has been identified
as the key molecule in integrin activation. It has been reported that Talin full length
protein has substantially less affect on integrin activation compared to Talin H domain.
Goksoy et el have shown through NMR analysis that there is an interaction between the
Talin rod domain and Talin H domain that holds Talin in its inactivate conformation,
inability to interact with integrin CT and subsequent activation. More precisely the Talin
PTB domain (F3 sub-domain) which binds to integrin CT, is masked by Talin rod
domain. The interaction between Talin rod domain and H domain is disrupted by PIP2
interaction or by a M319A mutation. Part of this interaction work was published at
Goksoy, E., Ma, Y.Q., Wang, X., Kong, X., Perera, D., Plow, E.F., and Qin, J. (2008).
Structural basis for the autoinhibition of talin in regulating integrin activation. Mol. Cell
31, 124-133.

NMR titration curve: Binding Interaction between Talin F3 subdomain and PIP2
In order to understand the chemical shift perturbation of Talin F3 upon PIP2
binding we performed an NMR titration experiment. The HSQC spectra were recorded
with of Talin F3 and PIP2(C4)/PIP2(C8) at increasing molar ratios. The Overlaying
HSQC spectra of Talin F3 and PIP2(C8) is shown in figure 1. The protein completely
precipitated after 1:1 molar ration of F3 and PIP2(C8). Talin F3 and PIP2(C4) was a
much stable complex. Thus the NMR titration experiment was performed with PIP2(C4).
131

The peak perturbation was recorded for all peaks of Talin F3, upon addition of 1:0.2,
1:0.4 1: 0.6,…1:3.25 of PIP2(C4) molar ratios. The chemical shift perturbation profile of
Talin F3 is shown below. The corresponding total chemical shift perturbation table for
1:3.25 molar ratio of Talin F3 vs. PIP2(C4) is shown below.

Figure 1. Appendix 2. Overlay of 1H-15N HSQC spectra of Talin F3 and
PIP2C8) titration. Black- HSQC Talin F3 free, green-Talin F3 and PIP2 at
1:0.25, red - 1:0.5 and purple - 1:0.75 molar ratios.
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Chemical shift perturbation map Talin F3 vs. PIP2(C4)
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Figure 2. Appendix 2. Chemical shift perturbation profile of all residue
of Talin F3 (309-405).

Chemical Shift Purtabations at 1: 3.25 molar ratio for talin F3 vs PIP2C4 titration
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0.00000
0.00010
0.00010
0.00000
0.00000
0.00010

0.0117
0.0077
0.0383
0.0000
0.0062
0.0105
0.0100
0.0031
0.0015
0.0105

0.02
0.00
0.00
0.02
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394
395
396
397
398
399
400
401
402
403
404
405

104.05
121.74
123.02
120.08
116.69
121.47
119.53
118.49
119.60
121.21
123.12
122.84

7.61
7.74
8.84
7.96
7.28
7.59
8.50
7.87
7.77
7.95
8.24
7.93

104.07
121.75
123.02
120.21
116.71
121.47
119.55
118.51
119.62
121.22
123.12
122.84

7.63
7.76
8.86
7.95
7.30
7.61
8.52
7.89
7.79
7.96
8.26
7.95

0.02
0.02
0.01
0.00
0.13
0.02
0.00
0.02
0.02
0.02
0.01
0.00
0.00

0.01
0.00
0.00
0.00
0.03
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00

0.00308
0.00154
0.00000
0.02002
0.00308
0.00000
0.00308
0.00308
0.00308
0.00154
0.00000
0.00000

0.00001
0.00000
0.00000
0.00040
0.00001
0.00000
0.00001
0.00001
0.00001
0.00000
0.00000
0.00000

0.00000
0.00000
0.00000
0.00090
0.00000
0.00000
0.00000
0.00000
0.00000
0.00010
0.00000
0.00000

0.0031
0.0015
0.0000
0.0361
0.0031
0.0000
0.0031
0.0031
0.0031
0.0101
0.0000
0.0000

Table 1. Appendix 2. Chemical shift perturbation table for Talin F3
and PIP2(C4) interaction. δ=[0.154∗∆Ν2+∆
∆H2]1/2

ITC experiment: Interaction between Talin Rod domain and Talin head domain
Talin is a 270KDa protein. As explained above, understanding the interaction
between Talin H domain 50KDa and Rod domain 220KDa through NMR is difficult as it
exceeds the size limitation for NMR which is 40KDa. As an alternative method we used
ITC to understand the interaction.
ITC has no limitation in size for analysis. The method was explained in chapter 2.
It provides a complete thermodynamic profile of the binding interaction.
We have performed an ITC experiment between Talin H and rod domain. A
50µM solution of Talin Rod domain was used in the sample cell and titrated against 1.0
mM solution of Talin head domain. The ITC titration curve is shown in the figure 3
below. The binding affinity between talin H and rod domain is 10µM.
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ITC for Talin H domain vs Talin rod domain
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Figure 3. Appendix 2. ITC titration curve for Talin Head domain and
Talin Rod domain interaction.
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ITC experiment: Talin H, F3, F2F3 domain and PIP2 interaction
These experiments were performed to understand the interaction between Talin H domain
and PIP2.
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Figure 4. Appendix 2. ITC titration curve for Talin F3 domain and
PIP2(C4). Talin F3 domain and PIP2(C4) shows a weak interaction.
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Figure 5. Appendix 2. ITC titration curve for Talin F2F3 domain and
PIP2(C6).
The ITC experiment of Talin F2F3 and PIP2(C6) interaction is shown in
figure 5. There was a continuous drift in the baseline during the experiment.
We are not able to calculate the thermodynamic profile of the binding
interaction due to the drift. However it is interesting to note, that the titration
between F2F3 and PIP2(C6) starts with an exothermic reaction, switches to
an endothermic reaction half way through the titration and finally saturates
at the last 4 injections. These types of interactions are an indication of a 1:2
molar ratio binding.
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Figure 6. Appendix 2. ITC Titration curve for Talin H domain and
PIP2(C6).
The ITC titration between Talin H domain and PIP2(C6) is shown in figure 6. The
data did fit into a 2 site binding interaction model indicating a 1:2 molar ratio
binding event. This is consistent with figure 5, F2F3 and Talin PIP2(C6) interaction
of a 1:2 molar ration interaction.
Our data of two site binding sites for PIP2 on F2F3 is consistent with: a recently
published paper and ongoing studies, where the two binding sites for PIP are on F2
and F3 sub-domains respectively (Saltel et al., 2009).
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NMR experiment: Talin F2F3 domain and PIP2(C8) interaction

Figure 7. Appendix 2. Overlay of 1H-15N HSQC spectra of Talin F2F3 and
PIP2C8) titration. Black- HSQC Talin F2F3 free, red – Talin F2F3 and PIP2
at 1:1 molar ratio.
The interaction between Talin F2F3 and PIP2(C8) is shown in figure 7. The protein
precipitates after 1:1 molar ratio of F2F3 and PIP2(C8). The chemical shifts are very
small compared to Talin F3 itself.
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